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Abstract 
Finite Element and Mechanobiological Modelling of Vascular 
Devices 
Houman Zahedmanesh 
There are two main surgical treatments for vascular diseases, (i) percutaneous stent 
deployment and (ii) replacement of an atherosclerotic artery with a vascular graft or tissue 
engineered blood vessel. The aim of this thesis was to develop computational models that 
could assist in the design of vascular stents and tissue engineered vascular grafts and scaffolds. 
In this context, finite element (FE) models of stent expansion in idealised and patient specific 
models of atherosclerotic arteries were developed. Different modelling strategies were 
investigated and an optimal modelling approach was identified which minimised 
computational cost without compromising accuracy. Numerical models of thin and thick strut 
stents were developed using this modelling approach to replicate the ISAR-STEREO clinical trial 
and the models identified arterial stresses as a suitable measure of stent induced vascular 
injury.  
In terms of evaluating vascular graft performance, mechanical characterisation experiments 
can be conducted in order to develop constitutive models that can be used in FE models of 
vascular grafts to predict their mechanical behaviour in-situ. In this context, bacterial cellulose 
(BC), a novel biomaterial, was mechanically characterised and a constitutive model was 
developed to describe its mechanical response. In addition, the interaction of smooth muscle 
cells with BC was studied using cell culture experiments. The constitutive model developed for 
BC was used as an input for a novel multi-scale mechanobiological modelling framework. The 
mechanobiological model was developed by coupling an FE model of a vascular scaffold and a 
lattice free agent based model of cell growth dynamics and remodelling in vascular scaffolds. 
By comparison with published in-vivo and in-vitro works, the model was found to successfully 
capture the key characteristics of vascular remodelling. It can therefore be used as a predictive 
tool for the growth and remodelling of vascular scaffolds and grafts. 
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1 Chapter 1                                                                                                  
Introduction 
1.1 Cardiovascular disease 
Cardiovascular diseases (CVD) take the lives of millions of people in the world and impose 
considerable economic and social burden on societies. Being the largest cause of morbidity 
and mortality, CVD account for approximately 48% of deaths or 4.3 million deaths per annum 
in Europe and 40% of death (2 million) in the European Union alone based on 2008 statistics 
(EHN 2010). CVD affect the heart and blood vessels and can take many forms such as high 
blood pressure, coronary artery disease, aneurysm, heart disease and stroke. They are one of 
the leading causes of long term morbidity and loss to the labour market. CVD are strongly 
associated with socioeconomic conditions and differences in CVD rates constitute the biggest 
single cause of health inequalities within the European member states (Simoons 2003; Health-
EU 2010). The financial burden for EU healthcare systems related to CVD has been estimated 
to be near €192 billion based on 2008 statistics, around 57% of which is due to healthcare 
costs, 21% due to productivity losses and 22% due to informal care of people with CVD (EHN 
2010). 
Coronary artery disease is a major type of CVD which is mainly due to development of 
atherosclerosis in coronary arteries and their consequent blockage which can ultimately lead 
to stroke or myocardial infarction. Coronary artery disease is the single most common cause of 
death in Europe and the European Union. Based on 2008 statistics, coronary artery disease 
accounts for 1.92 million deaths in Europe and over 741,000 deaths each year in the European 
Union per annum (AHA 2010b).    
CVD and specifically atherosclerosis are linked to behaviours and lifestyles, therefore effective 
prevention strategies can be adopted to reduce the risk of atherosclerosis by better control 
over key factors such as smoking, nutrition and physical activity, alcohol consumption, and 
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psychosocial stress. However, once the disease develops the only effective treatment is 
surgical intervention. Currently two major surgical procedures are practiced to treat patients 
with atherosclerosis: 
(i) Invasive surgical procedures such as open heart surgery where a vascular graft is 
used to bypass the diseased artery or fully replace it 
(ii) Minimally invasive surgery including balloon angioplasty and stent deployment. 
1.2 Objectives 
Vascular grafts and stents are the main vascular implants used in the aforementioned surgical 
procedures. In bypass procedures usually an autograft such as the saphenous vein is used, 
however, in more than one third of the cases a suitable autograft is not available (Sarkar et al., 
2007b). This limitation has motivated development of artificial blood vessels including 
synthetic grafts and tissue engineered blood vessels. On the other hand different types of 
stents have been developed and there is an intense ongoing research to improve the 
performance of stents. The main issue with both of these devices is the problem of re-
narrowing following their implantation partly due to over-proliferation of vascular smooth 
muscle cells (VSMCs) (Lemson et al., 2000; Mitra et al., 2006).  
Several studies have elucidated the significant role of biomechanics in the performance of 
these devices and have highlighted the determining influence of biomechanics related factors 
on their short and long term implantation outcome. Computational methods offer several 
advantages in assessing the biomechanics of medical devices such as prediction of system 
behaviours, biomechanical design optimisation, and also efficiency and cost effectiveness in 
the design cycle. Given the advantages of computational methods, this study aims to develop 
computational models which can help to address the following key biomechanics related 
challenges in relation to vascular grafts and stents, (also see Figure 1-1): 
(i) Optimise stent designs in order to minimise the re-narrowing of blood vessels 
following stent implantation due to in-stent restenosis. 
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(ii) Optimise the mechanical properties of vascular grafts and their design to minimise re-
narrowing of grafts following implantation due to development of intimal hyperplasia. 
(iii) Develop novel tissue engineering strategies informed by mechanics related cues in 
order to enhance the remodelling of vascular scaffolds and minimise intimal 
hyperplasia. 
 
 
  
Vascular grafts 
Synthetic Grafts: 
Biomechanics related challenges: 
(i) Intimal hyperplasia due to compliance 
mismatch 
Tissue Engineered Blood Vessels: 
Biomechanics related challenges: 
(i) Mechanoregulation of tissue 
remodelling 
(ii) Intimal hyperplasia 
 
Key vascular implants used 
in surgical treatment of 
vascular disease 
Stents 
Biomechanics related challenges: 
(i) In-stent restenosis due to stent induced   
arterial injury 
Figure ‎1-1: Overall objectives of this study  
4 
 
2 Chapter 2                                                                                                      
Literature Review 
2.1 Arteries, Structure and Diseases: 
Arteries have the vital role of blood supply to organs in the body. In spite of their simple 
geometry and appearance as a tubular conduit for blood flow, arteries take advantage of a 
tremendously sophisticated and intriguing structure. This sophisticated structure of arteries 
helps regulate the blood flow and pressure in the farthest organs from the heart. Their passive 
viscoelastic response combined with their ability to actively contract depending on the 
physiological demands, complements the role of heart in the blood circulation system.  
Arteries consist of three main layers, (i) the tunica intima, which is the innermost layer of an 
artery, (ii) the tunica media as the intermediate layer of arteries, and (iii) the tunica adventitia 
which is the outermost layer as can be seen in Figure 2-1. Arteries are generally categorised as 
elastic or muscular depending on the composition of the medial layer. In elastic arteries, the 
media contains comparably higher number of elastic laminae. In contrast, in muscular arteries 
the media is dominated by smooth muscle cells (SMCs) and the elastic content is lower. Large 
arteries are mainly classified as elastic arteries and the small diameter arteries and the arteries 
approaching the peripheral organs are classified as muscular (Rhodin et al., 1980) 
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Figure ‎2-1 Diagram of a healthy elastic artery and its components, taken from Holzapfel et 
al., 2000a. 
The intima functions as an interface between the thrombogenic media and blood. This layer is 
composed of a single layer of endothelial cells lining a thin basal lamina (Rhodin et al. 1980). 
Along with ageing of arteries, a normal thickening of the intima occurs due to development of 
non-pathological intimal hyperplasia (Stary et al., 1992; Subbotin 2007). This process is a non-
atherosclerotic process and involves proliferation of intimal cells, mainly myofibroblasts, which 
leads to an increase of extracellular matrix containing mainly collagen fibres with dispersed 
smooth muscle cells through the layer (Canham et al., 1989). The intima adapts itself overtime 
to baseline levels of stress. As a result, in aged human arteries the intimal layer has significant 
load bearing capacity (Holzapfel et al., 2005a).  
The media is mainly comprised of smooth muscle cells (SMCs), bundles of collagen fibrils, a 
network of elastin fibrils and proteoglycans, (Clark et al., 1979; Pedrizzetti et al., 2003). The 
collagen fibres are aligned in two transverse continuous helical orientations. The helix has a 
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small pitch, rendering the arteries strong enough in the circumferential direction to resist high 
blood pressures.  
The adventitia mainly consists of fibroblasts and the ground-matrix where collagen fibres are 
organized in thick bundles. Collagen fibres mainly of type I (von der Mark 1981) are arranged 
within the ground matrix and form a fibrous tissue. Polarized light microscopy of the structure 
of adventitia has shown that collagen fibres form two helically arranged families of fibres with 
large dispersion from the mean orientation (Canham et al., 1989).  
Each of the arterial cell types play a vital role in the arteries and any disruption in their 
function will cause a pathological condition. Endothelial cells (ECs) which line the lumen of 
arteries create a barrier between the arterial wall and the blood vessel. ECs prevent 
thrombosis formation due to direct contact between blood and the arterial components. They 
also function as a layer which prevents proliferation of smooth muscle cells towards the lumen 
by synthesis of chemokines such as nitric oxide which has antiproliferative influence on the 
underlying SMCs (Lemson et al., 2000). Also they prevent fusion of lipids in the blood flow into 
the medial layer which can create foam cells, an event that is postulated to occur in the early 
stages of atherosclerosis (Kleemann et al., 2008). SMCs on the other hand synthesise 
extracellular matrix components such as elastin and collagen and are also in charge of 
vasoactive contraction of arteries. Fibroblasts, in the adventitia, produce extracellular matrix 
components, mainly collagen, which are organised in thick bundles strengthening the arterial 
wall.  
Arteries are susceptible to many different diseases, most importantly atherosclerosis and 
aneurysms. Atherosclerosis is a disease where fatty material called plaque builds up in the 
lumen of arteries and makes them less flexible. Plaque build-up reduces the amount of blood 
and oxygen available for vital organs such as the heart and brain and consequently can lead to 
stroke and myocardial infarction, see Figure 2-2. 
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Figure ‎2-2: Progression of atherosclerosis, taken from AHA 2010a. 
Atherosclerosis in arteries develops following a cascade of inflammatory events in response to 
accumulation of lipoproteins in the arterial wall (Steinberg 2005). It occurs in many different 
arteries such as the coronary arteries, aorta, carotid and even arteries approaching the 
extremities such as the iliac artery. It has been shown that atherosclerosis usually occurs in 
locations where blood flow perturbations take place such as near bifurcations. Damage to the 
endothelium can increase penetration of low density lipoproteins (LDL) into the intima and 
increase the risk of atherosclerosis (Steinberg 2005; Vukovic et al., 2006). Formation of fatty 
streaks and accumulation of cellular and extracellular material between the intima and media 
are the first signs of an atherosclerotic plaque. Following penetration of lipoproteins into the 
arterial wall, immune cells (monocytes and T-cells) migrate from the circulatory system into 
the arterial wall and differentiate into machrophages. Machrophages then take up the 
accumulated lipoproteins and transform into foam cells. The macrophages and T-cells in the 
arterial wall then synthesise a wide variety of pro-inflammatory cytokines including the 
Interleukin family which are considered to be a key player in the chronic inflammation typical 
of atherosclerosis (Vukovic et al., 2006; Kleeman et al., 2008).   
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Accumulation of lipids and foam cells in the arterial wall consequently leads to atherosclerotic 
swelling of the arterial wall. The chronic inflammation increases the chemotactic migration and 
proliferation of SMCs from media to intima which, in turn also produce inflammatory 
mediators, monocyte chemoattractants and even take up LDL (Steinberg 2005). Smooth 
muscle cells are the predominant arterial cells in the larger atherosclerotic lesions and 
contribute to lesion formation and progression by synthesis of extracellular matrix products 
(Steinberg 2005). 
Based on the American Heart Association, atherosclerotic plaques are classified into six types 
depending on the progression of the disease, see Figure 2-3.  Atherosclerotic plaque Type IV 
and type V which are also referred to as atheroma and fibroatheroma respectively, may 
develop fissures, hematoma and thrombosis which makes them clinically relevant (Stary et al., 
1995). Mortality and morbidity due to atherosclerosis is mainly due to type IV and type V 
lesions in which disruptions of the lesion surface, hematoma or haemorrhage, and thrombotic 
deposits have developed. Type IV or V lesions with one or more of these additional features are 
classified as type VI and may also be referred to as complicated lesions (Stary et al., 1995). 
Atherosclerosis has also been associated with development of aneurysms given that type IV, V 
and VI lesions appear to contribute to localised dilatations of the vascular wall and cause 
development of aneurysms (Stary et al., 1995).  
Atherosclerotic plaques are also categorised into stable and vulnerable plaques based on their 
risk of rupture. Stable plaques are characterised by a higher concentration of SMCs and 
collagen and lower amount of inflammatory cells. Although a stable plaque is usually thick and 
can cause a higher degree of stenosis but the thicker and stiffer fibrous caps in such plaques 
protects them from rupture and hence they constitute a less serious clinical problem. In stark 
contrast are the vulnerable plaques which are thinner and are richer in inflammatory and lipid-
laden cells. These plaques have lower mechanical resistance and are prone to rupture 
specifically in the plaque shoulder region where the concentration of macrophages is higher. 
Plaques tend to rupture at sites of increased macrophage and reduced VSMC content. Rupture 
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of the plaque causes the contents of the lipid core to come into contact with blood clotting 
factors and creates blood clots and thrombosis which can occlude the blood vessel and cause 
stroke (Stoneman et al., 2004). 
 
 
Figure ‎2-3: Types of atherosclerotic plaque and their characteristics, taken from Stary et al., 
1995. 
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Although healthy diet and life style can help prevent atherosclerosis, currently there are no 
pharmaceutical treatments for atherosclerotic plaques and in cases where the arteries are 
severely occluded due to atherosclerosis or where the plaque is prone to rupture the only 
possible treatment is surgical intervention. Several surgical techniques have been used to treat 
patients with severe arterial diseases such as atherosclerosis and aneurysms. These techniques 
can range from minimally invasive techniques including percutaneous transluminal balloon 
angioplasty and stent deployment to highly invasive methods such as open heart surgery for 
coronary bypass procedures or replacement of an aneurysmal abdominal aorta with a 
prosthetic graft.   
Roughly one third of the patients with coronary artery disease undergo coronary angioplasty 
and stenting which constitutes nearly one million patients annually in the United States alone 
(Michaels et al., 2002). The procedure takes 1 to 2 hours and is conducted using local 
anaesthesia on patients who are mildly sedated. Most patients stay overnight in the hospital 
for observation and are discharged the following morning. The patient can then resume 
normal activities in a week. Following the procedure the patients are treated with anti-platelet 
drugs such as Clopidogrel for a period of 30 days and Aspirin in the long term to prevent blood 
clotting on the stent.  
However, there are cases where coronary angioplasty and stenting may not be performed 
(Michaels et al., 2002). For instance when the coronary artery is too small, the plaque is highly 
vulnerable to rupture, the plaque is highly calcified and where there is a complete blockage 
that cannot be crossed with the balloon and stent. Under such conditions open heart bypass 
procedure is the only possible treatment.   
In bypass procedures the surgeon needs a vascular graft to bypass the blocked portion of the 
coronary artery, see Figure 2-4. The most commonly used autografts are the saphenous vein 
from the leg, the internal mammary artery from the chest, and the radial artery from the arm. 
During the surgery a heart-lung machine maintains circulation while the surgeon operates on 
the heart. The patient is operated under general anaesthesia and stays 4 to 7 days under 
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observation in the hospital. It may take up to 3 months to fully recover from the surgery. 
However, in many cases a suitable autograft is not available due to previous use, inadequate 
calibre or varicosity and the surgeon needs to use a prosthetic graft. The coronary bypass 
surgery is a typical example of where prosthetic vascular grafts are needed for the treatment 
of vascular diseases. In addition there are many other cases where surgeons need prosthetic 
vascular grafts with high patency rates such as in patients who undergo dialysis and need 
vascular grafts to be implanted as arteriovenous fistulas and in patients with abdominal aortic 
aneurysms who need to replace the aneurysmal artery with a graft. 
The prevalence of arterial diseases and the central role that stents and vascular grafts play in 
their successful treatment has motivated tremendous efforts towards improving their 
performance.  In the following sections each of these devices are reviewed in more detail and 
their limitations and challenges are discussed. 
 
Figure ‎2-4: Schematic of a coronary bypass procedure; the bypass graft is connected to the 
aorta at the proximal end and to the atherosclerotic coronary artery downstream from the 
plaque, taken from Michaels et al., 2002. 
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2.2 Vascular Devices 
As discussed earlier, stents and vascular grafts are the two main devices used for the 
treatment of vascular disease. However there are several limitations and challenges with their 
use and outcome which has motivated tremendous endeavours to improve their design and 
performance. Many of these challenges have been associated with biomechanical factors. In 
this section, these two main vascular devices are explained and different aspects of their 
design are discussed specifically from a biomechanical and mechanobiological point of view 
which is the focus of this thesis. 
It is worth mentioning that in this review vascular grafts are categorised into two groups, 
namely (i) synthetic vascular grafts and (ii) tissue engineered blood vessels, which are 
discussed separately. However, it should be acknowledged that with the recent developments 
in the field of biomaterials the difference between synthetic grafts as simple mechanical 
conduits, and tissue engineered blood vessels as live but artificial blood vessels is fading. This is 
due to the fact that the classical tissue engineering paradigm that involves in-vitro culture of 
patient cells into a scaffold and its implantation into body following in-vitro maturation, is 
being replaced in favour of a more practical approach towards developing off the shelf grafts 
which can be readily implanted into body to remodel and mature in-vivo. 
2.2.1 Endovascular Coronary Stents  
An estimated 652,000 percutaneous coronary interventions involving stent deployments were 
performed in the United States in 2006 to restore the blood supply to the hearts of patients 
suffering from cardiovascular diseases (AHA 2010a). Percutanesous coronary procedures have 
several significant advantages over open heart surgery, in particular the fact that they are 
minimally invasive procedures. Percutaneous coronary stenting was introduced as a solution 
to the elastic recoil of the atherosclerotic arteries following percutaneous angioplasty. In 
percutaneous angioplasty a balloon is used to permanently expand the stenosis and restore 
the blood flow, however, elastic recoil of the stenosed arteries usually minimises luminal gain. 
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The degree of this elastic recoil depends on the morphology of the atherosclerotic plaque. In 
cases where the plaque is eccentric the non-diseased segment of the artery may expand 
elastically under the pressure and the more rigid atherosclerotic plaque may remain 
undeformed. Therefore, luminal gain may be small following deflation of the angioplasty 
balloon. The majority of stents are delivered to the pathological region in a crimped 
configuration mounted on a folded balloon, at the tip of a percutaneously inserted catheter 
and expanded in the stenosed region by inflation of the folded balloon, see Figure 2-5. 
Following expansion they scaffold the deformed artery open and prevent its elastic recoil. In 
spite of the fact that stents have improved the luminal gain in comparison to angioplasty and 
proved to have a better long term outcome, new complications emerged after introducing 
stents into clinical use. Namely, intimal cells were found to proliferate due to the severity of 
the injury caused to the arterial wall by the stent often leading to excessive neointimal 
hyperplasia and re-stenosis of the artery (Grewe et al., 2000; Mitra et al., 2006).  
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Figure ‎2-5: Schematic of a balloon expandable coronary stent deployment procedure, taken 
from NHLBI 2010. 
In recent years drug eluting stents, coated with antiproliferative drugs, have reduced the 
restenosis rate compared to bare metal stents (Morice et al., 2002; Sousa et al., 2005; Hara et 
al., 2006; Serruys et al., 2006). Several mechanical factors linked to stent design and 
deployment have also been postulated to be involved in the development of this pathological 
condition however, which are not eliminated by such pharmaceutical interventions (Mc Clean 
et al., 2002; Timmins et al., 2007). In addition a higher rate of late thrombosis in drug-eluting 
stents due to their delayed healing (McFadden et al. 2004, Iakovou et al. 2005, Bavry et al. 
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2006, Daemen 2007) has raised uncertainty over their use urging researchers to focus further 
on improving the performance of bare metal stents by improving their mechanical design. The 
delivery of anti-proliferative drugs to surrounding tissue is also significantly influenced by the 
stent design (Hwang et al., 2001). Endothelial denudation and vessel wall injury during stent 
deployment and alteration of the stress-strain field in the arterial wall following stent 
deployment are hypothesised to be some of the most important factors contributing to in-
stent restenosis (Schwartz et al., 1992; Kornowski et al., 1998; Mitra et al., 2006).  
During the expansion of the stent, high stresses cause injury to the artery which leads into 
thrombosis formation in the arterial wall. The arterial injury initiates a cascade of inflammatory 
events which can lead to in-stent restenosis. After stent implantation adhesion of the 
thrombocytes at the injury sites are observed. These thrombocytes produce growth factors in 
the thrombosis sites and initiate chemotactic migration and proliferation of medial SMCs. The 
cytokines produced by the inflammatory cells not only serve as mitogens for SMCs but also 
upregulate synthesis of extracellular matrix by SMCs (Wieneke et al., 1999; Welt et al., 2002; 
Mitra et al., 2006).  
A close correlation has been observed between the degree of inflammation and the neo-
intimal thickness which suggests that inflammation caused by the arterial injury plays a central 
role in the formation of in-stent restenosis (Wieneke et al., 1999; Welt et al., 2002; Mitra et al., 
2006). The laceration lesions are invaded by SMCs with mainly a synthetic phenotype. These 
cells produce extracellular matrix components such as collagen, elastin and proteoglycans and 
make up the intimal hyperplasia tissue.  This inflammatory response usually takes up to 6 
month after which further luminal loss is minimal (Wieneke et al., 1999; Sousa et al., 2005). 
Rupture of the internal elastic lamina is followed by a significant intimal hyperplasia and the 
severity of initimal hyperplasia is increased once the laceration extends to the media, external 
elastic lamina and adventitia respectively (Wieneke et al., 1999). Therefore the degree of vessel 
injury is a major determinant of the extent of restenosis and hence one key aspect of stent 
16 
 
design is to minimise the stress level in the arterial wall following stent deployment while still 
obtaining luminal gain and blood flow restoration. 
2.2.2 Synthetic Vascular Grafts 
 
Currently, it is possible to replace large arteries with synthetic grafts made of materials such as 
polyester and expanded polytetrafluoroethylene (ePTFE) (Bäckdahl et al., 2007), however their 
use is limited to large arteries given their thrombogenicity (Sarkar et al., 2007a) and their high 
propensity to develop intimal hyperplasia (IH) (Pomposelli et al., 1998, Tarry et al., 1998, 
Helenius et al., 2006). Development of suitable grafts to substitute for small size arteries (<6 
mm in diameter), such as coronary arteries, still remains a daunting challenge due to the 
development of intimal hyperplasia and thrombus formation (Salacinski et al., 2001).  Due to 
these challenges only 50% of synthetic grafts survive even two years (Salacinski et al., 2001).  
The level of intimal hyperplasia has been found to depend on the graft material (Salacinski et 
al., 2001). It has been found that the severity of intimal hyperplasia is highest in the 
anastomotic sites specifically in the distal anastomosis (Salacinski et al., 2001). Very similar to 
the intimal hyperplasia occurring in the in-stent restenosis, it is known that intimal hyperplasia 
in the vascular grafts involves proliferation and migration of smooth muscle cells towards the 
lumen of the graft and excessive production of extracellular matrix. It is believed that SMCs, 
ECs, inflammatory cells (i.e. thrombocytes (platelets), monocytes, macrophages and cytokines 
(i.e. growth factors) are involved in development of IH in vascular grafts (Mitchell 2009). 
Development of IH following synthetic vascular graft implantation procedures occurs through 
two major mechanisms, namely (i) immune system related, and (ii) compliance mismatch 
related (Lemson et al., 2000; Salacinski et al., 2001; Mitchell 2009). In the immune system 
related mechanism, the foreign body response activates macrophages and platelets which 
release growth factors such as TGF-β and PDGF which promote formation of a SMC dominated 
neo-intima layer on the luminal surface of the graft. The origin of these cells can be the 
vascular precursor cells in the blood stream which differentiate into SMCs and also SMCs from 
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the adjacent artery which proliferate and migrate towards the intima in the anastomotic site 
(Mitchell 2009).   
Compliance is a mechanical property of a tube that expresses the change in diameter with 
respect to luminal pressure change. A direct relationship has been found between compliance 
of vascular grafts and their long term patency, see Figure 2-6. The compliance related 
mechanism which contributes to the development of IH is driven by wall stretch and fluid flow 
changes. It has been shown that increases in wall cyclic stretch inhibits rat vascular SMCs 
proliferation and enhances apoptosis (Morrow et al., 2005) and in another study by Sotoudeh 
et al., (2002) cyclic stretch was found to increase porcine VSMC apoptosis. The fact that over-
proliferation of SMCs is the main mechanism involved in IH development (Subbotin 2007) 
suggests a strong link between the reduction in cyclic stretch due to low compliance of the 
grafts and the development of IH.  
On the other hand, several studies have shown the influence of compliance mismatch on 
hemodynamic factors. Stewart et al., (2004) numerically showed that low compliance of grafts 
disturbs the transport and distribution of growth factors and lowers the wall shear stress 
particularly in the vicinity of the distal suture in a model of an end-to-end anastomosis. In 
another study Stewart et al., (1992) experimentally showed that under pulsatile flow, low graft 
compliance can trap particles less than 40 μm in size near the wall at the distal anastomosis 
suggesting that this may contribute to the development of intimal hyperplasia.  Zones of low 
shear stress and flow separation in the anastomotic region cause platelet adhesion and 
activation which release growth factors (Lemson et al., 2000).  
Although the immune system related IH development may be treated by pharmaceutical 
interventions and surface modifications (Tseng et al., 1998; Schepers et al., 2006) the 
compliance mismatch related IH seems to be the achilles’ heel of most available synthetic 
grafts and tissue engineered scaffolds. Therefore, it is fundamental to build new vascular grafts 
which can exhibit a compliance response similar to arteries.  
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Figure ‎2-6: Influence of compliance on graft patency, adapted from Salacinski et al., 2001. 
2.2.3 Tissue Engineered Blood Vessels  
The growing demand for development of substitutes for native blood vessels due to 
cardiovascular diseases and the limitations of the synthetic grafts have promoted tissue 
engineering approaches towards development of live blood vessels that can function close to 
that of the native vessels. A tissue engineered construct is composed of two main constituents, 
namely (i) scaffold and (ii) cells. Scaffolds confer mechanical integrity to the construct and 
provide a three dimensional structure onto which cells adhere and grow. Cells grow within the 
scaffold and are responsible for its biological functionality.  
Since Weinberg and Bell (1986) reported in-vitro development of blood vessels using collagen 
as a scaffold and bovine aortic ECs, SMCs and adventitial fibroblasts, there have been 
significant improvements in the area of vascular tissue engineering. The general approach in 
tissue engineering is to seed cells on scaffolds and proceed by in-vitro culture of cells or in-vivo 
implantation. Scaffolds may be degradable where they are gradually resorbed and leave only 
the regenerated tissue, or alternatively they may be nondegradable and remain as a 
constituent of the generated tissue.    
A successful tissue engineered blood vessel should be non-thrombogenic, non-immunogenic 
and should have similar mechanical compliance to native arteries (Nerem et al., 2001; 
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Heyligers et al., 2005). Several types of cells have been used for vascular tissue engineering 
including mature vascular cells such as SMCs and ECs, and also embryonic and adult stem cells 
(Isenberg et al., 2006; Zhang et al., 2007; Pankajakshan et al., 2010). Also several different 
types of scaffolds have been used for engineering blood vessels including nature protein 
scaffolds, synthetic polymer scaffolds, decellularized vessels and hybrid scaffolds.  
Natural proteins such as collagen, elastin and fibrin are extremely favourable given that they 
are highly biocompatible and create a perfect matrix for vascular cell attachment and growth. 
As a result collagen gels have been extensively used to engineer arterial constructs. However 
collagen gels suffer from lack of mechanical strength to withstand arterial blood pressure and 
consequently various techniques such as glycation, reinforcement with degradable and non-
degradable meshes and sleeves, and electro-spinning have been used to strengthen collagen 
gel based scaffolds (Seliktar et al., 2000; Berglund et al., 2003; Isenberg et al., 2003; Berglund 
et al., 2004).  
Elastin is another dominant extracellular matrix (ECM) protein which confers elasticity and 
recoiling to the blood vessels, however, its synthesis in most available scaffolds has proven 
very poor. This limitation has motivated the use of purified elastin as scaffolds, however, 
purified elastin scaffolds do not provide sufficient mechanical strength to be used as conduits 
in the arterial system (Hinds et al., 2006). Therefore several methods such as using allogenic 
tissue support and incorporation of soluble elastin onto other types of scaffolds have been 
used (Pankajakshan et al., 2010).  
Another natural protein scaffold which has recently gained significant attention is fibrin. Cells 
have shown higher elastin and collagen synthesis in fibrin gels compared to collagen gel 
scaffolds (Long et al., 2003; Pankajakshan et al., 2010). Mature crosslinked fibin is relatively 
nonthrombogenic and nonreactive to platelets compared to other surfaces (Pankajakshan et 
al., 2010). Albeit, similar to most other nature protein scaffolds one major limitation of fibrin is 
its low mechanical strength. 
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In addition several synthetic polymers have been used as scaffolds for arterial tissue 
engineering.  Some of the important advantages of the synthetic polymers include their 
availability, low price and reproducibility. Polyglycolic acid (PGA) is widely used in vascular 
tissue engineering and was used by Niklason et al., (1999) to produce an autologous graft 
which was later implanted into the arterial system. A poly(caprolactone)-poly(lactic acid), PCL-
PLA, copolymer tube reinforced with woven PGA was successfully used to reconstruct the 
peripheral pulmonary artery in a 4-year-old girl (Shin’oka et al., 2001) and later in twenty–
three additional cases (Shin’oka et al., 2005). Poly( L-lactic acid) PLLA (Mooney et al., 1996), 
Poly (D,L-Lactic-co-Glycolic acid) PLGA (Mooney et al., 1996), poly (4-hydroxybutyrate acid) 
(Opitz et al., 2004), and co-polymer of PGA and polyhydroxyalkanoate (PHA) (Shum-Tim et al., 
1999) have been used as vascular scaffolds in the form of gels or electro-spun matrices. 
However one important limitation of their use is the cellular toxicity of their breakdown 
products which can cause adverse effects (Zhang et al., 2007). In addition, in order to maintain 
their mechanical strength the rate of their resorption and the rate of tissue regeneration by 
cells should be equal which is a very challenging problem.  
Decellularized vessels have also been extensively used as tissue engineering scaffolds and have 
shown good biocompatibility and have similar mechanical properties to that of native arteries. 
Decellularization is usually performed by detergents, enzyme inhibitors and buffers. Teebken 
et al., (2000) successfully constructed vascular grafts by seeding human ECs and 
myofibroblasts on decellularized porcine aortas.  However, the risk of trans-species infection 
transfer is a drawback and therefore the better solution would be decellularization of 
autologous vessels such as human autologous veins and culture of autologous cells under 
arterial conditions.  
A novel biosynthetic biomaterial which has recently gained significant attention for vascular 
tissue engineering applications is Bacterial Cellulose (BC). BC is a polysaccharide produced by 
Acetobacter Xylinum Bacteria which exhibits high mechanical strength, high water content, 
high crystallinity and an ultra-fine highly pure nanofibril network similar to that of collagen 
21 
 
(Bäckdahl et al., 2006). It is possible to fabricate BC tubes that can be used for the replacement 
of small to large size arteries with various dimensions (Bodin et al., 2007). In addition, BC has 
been implanted into rats without eliciting any foreign body or inflammatory response 
(Helenius et al., 2006) and it has been shown that the surface of BC induces the lowest 
thrombogenicity when compared to Dacron and ePTFE (Fink et al., 2010).  BC tubes have 
shown good mechanical strength exhibiting a burst pressure of up to 880 mmHg (Bodin et al., 
2007) Furthermore, BC tubes may have the potential to be used as tissue engineered blood 
vessel scaffolds given that SMCs grow and proliferate on them (Bäckdahl et al., 2006; Bäckdahl 
et al., 2008) and cultivation of ECs onto the lumen of BC tubes has led to development of a 
confluent layer of cells (Helenius et al., 2006; Bodin et al., 2007).  
In spite of the favourable characteristics of BC for tissue engineering, in-depth investigation of 
the mechanical properties of BC is required to further support its clinical use as a vascular 
tissue engineering scaffold or graft. Specifically, the compliance response of BC tubes and their 
permeability should be investigated to ensure compliance matching with host arteries and 
suitable transport of nutrients and other vital chemicals within BC. 
Two of the most important limitations which are common in the available scaffolds are their 
low burst pressure and compliance mismatch with host arteries. A method which has proven 
successful in improving these mechanical properties of the tissue engineered constructs is 
their in-vitro mechanical conditioning whereby the cell seeded scaffolds are cultured in-vitro 
and exposed to gradually increasing pulsatile flow and pressure. Several studies have shown 
improved extracellular matrix synthesis and mechanical properties in vascular tissue 
engineered constructs using this procedure (Jeong  et al., 2005; Stankus et al., 2006; Hahn et 
al., 2007). These observations highlight the key role of mechanics and mechanoregulation in 
vascular tissue engineering and necessitate in-depth mechanical characterisation of vascular 
scaffolds to ensure their potential for tissue engineering. In addition, the role of mechanical 
stimuli on remodelling and patterning of tissue engineered constructs has long been proven. 
For example, it is known that application of cyclic strain to VSMCs regulates their proliferation, 
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apoptosis, phenotype and orientation (Nikolovski et al., 2003; Liu et al., 2008; Colombo 2009). 
Given that tissue level loads translate into mechanical stimuli for adherent cells through a 
scaffold, it is crucial to devise a suitable in-vitro mechanical stimulation regime and also to 
optimise the mechanical properties of vascular scaffolds in order to provide cells with optimal 
mechanical signals which enhance tissue regeneration and remodelling.   
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2.3 Computational Modelling in Vascular Device Technology 
As discussed in the previous section, mechanical factors significantly contribute to the 
performance of stents and vascular grafts. High stresses can cause injury to the arterial wall 
following stent deployment and the challenging issue of compliance and mechanoregulation in 
vascular grafts and tissue engineered blood vessels are important aspects of their design. 
Computational models have gained significant attention in the recent years to address the 
challenges involved in vascular device technology. Therefore this thesis is mainly focused on 
development of computational models which can address the aforementioned challenges with 
stents and vascular grafts. However, the most important building block required for the 
construction of such models is a thorough understanding of arterial biomechanics and 
development of precise constitutive models for arteries. Therefore this section starts with a 
review of arterial biomechanics and proceeds with a review of finite element (FE) modelling 
and mechanobiological modelling of vascular devices. 
2.3.1 Arterial Biomechanics 
A distinctive mechanical response of arterial tissues in a simple tensile test is their initial linear 
response with relatively large extension at low loads followed by stiffening at higher 
extensions, see Figure 2-7. This response is related to the distribution and configuration of 
collagen fibres which are initially wavy and in a crimped configuration.  In the initial linear 
region of the force-extension curve of arterial tissue the load is mainly borne by elastin fibres. 
As the tissue is further stretched, collagen fibres straighten, reach their natural length and 
become more aligned with the direction of tension.  Thereby, they resist further extension 
with their increased stiffness; a response which corresponds to the steeper region of the force-
extension curve. This was well demonstrated by Roach and Burton (1959) by selectively 
digesting collagen and elastin from arterial samples and performing uniaxial extension tests on 
them. As can be seen in Figure 2-8, when trypsin was used to remove elastin, the remaining 
tissue demonstrated the mechanical response of collagen. Alternatively, when formic acid 
digestion was used, the remaining tissue demonstrated the mechanical response of elastin 
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fibres. In addition, the arterial wall matrix contains proteoglycans which are also mechanically 
relevant as it has been shown that their removal increases arterial wall stiffness (Pedrizzetti et 
al.,2003). 
 
 
 
 
 
               
Figure ‎2-7: Characteristic J-shaped uniaxial tensile test curve of arterial tissues 
 
 
Figure ‎2-8: How elastin and collagen fibres affect arterial stress-strain response. Trypsin 
selectively digests elastin and formic acid selectively digests collagen, taken from Roach and 
Burton 1957. 
  
Force 
Extension 
25 
 
The force-extension response of arterial tissue due to their sophisticated composite structure 
prevents any instability in the structure of arteries. The significance of this response is better 
explained by comparison with a rubber tube. The law of Laplace: T=PR, can be used to explain 
the inflation behaviour of thin cylinders, where T is the circumferential tension, P is the 
pressure and R is the internal radius, (Shadwick 1999). The nonlinear elastic behaviour of an 
artery and a rubber tube can be represented as a plot of T verses R. If Laplace relationships are 
plotted as straight lines for different pressures, the lines of each pressure intersect with the 
arterial response curve only at one point. In contrast in the case of the rubber tube there are 
two intersection points with the curve at pressure P2, see Figure 2-9. This demonstrates the 
instability of the rubber tube at pressure P2 which can cause irregular expansion of the tube at 
this pressure characterised by aneurysm like swellings at some locations. One can imagine the 
catastrophic consequences if such instability were to occur in an artery or a vascular graft; with 
possible aneurysm formation and consequent rupture.  
 
 
Figure ‎2-9: Comparison between radius-tension response of a rubber tube with arteries 
explaining how the structure of arteries prevents mechanical instability, taken from 
Shadwick 1999. 
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2.3.1.1 Constitutive Modelling of Arterial Tissues: 
From a biomechanical point of view, mechanical characterisation of arteries requires 
development of their constitutive equations which can only be determined by experiments. 
The simplest experiments that can be performed on an artery is a uniaxial extension test 
whereby the stress-strain relationship of the artery under uniaxial loading is deduced. As 
discussed earlier, the stress-stiffening response of arteries deviates from Hooke’s law given 
that Hooke’s law only holds in the case of linearly elastic materials. In addition once arteries 
are subject to cyclicly varying strain, the stress-strain curves show a hysteresis loop with each 
cycle. This hysteresis loop diminishes with succeeding cycles and tends towards a steady state 
after a number of cycles, see Figure 2-10. In the context of mechanical characterisation and 
constitutive model development usually only the steady state stress-strain response is used 
and the first number of cycles which are applied to obtain steady state are called 
preconditioning cycles (Humphrey et al., 2004). 
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Figure ‎2-10: Noncoincident loading and unloading, evidence of viscous dissipation, 
 adapted from Humphrey et al., 2004.  
Strain 
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One important property of arterial tissues is their high water content which renders the 
arterial tissue incompressible. Water itself is incompressible and the arterial wall is composed 
of approximately 70% water. Incompressibility is an important assumption which is used in the 
development of constitutive models for arteries or any other biomaterial with high water 
content such as hydrogels. It states that conservation of volume should hold, thereby the 
product of the principal stretches in a sample should be equal to one. 
λ1λ2λ3=1 
Mooney (1940) for the first time developed a theory for the study of the mechanics of rubber-
like materials. This work was followed by a number of studies such as the study by Treloar 
(1944) and Rivlin (1948a, 1948b) which shaped the seminal works on the theory of 
hyperelasticty for rubber-like materials.  
Later, Tickner and sacks (1967) presented a theory for the study of arterial elasticity for the 
first time which was built on the approach developed earlier for rubber-like materials. The 
theory assumed a strain energy density function, W, for the material as a function of principal 
stretches (λ1 , λ2 , λ3) or the stretch invariants (   ,    ,   ). Usually rubberlike materials which can 
undergo large elastic deformations without permanent deformation are called hyperelastic 
materials. Strain energy density functions developed for hyperelastic materials are called 
hyperelastic constitutive equations. Although arteries are not perfectly hyperelastic materials 
given that they exhibit some hysteresis under cyclical loads, Fung reported in late 1960s that 
the behaviour of soft tissue tends not to depend strongly on the strain rate and hyperelastic 
models could model their behaviour reasonably well if the loading and unloading were treated 
separately as elastic. This concept was termed pseudo-elasticity and was first suggested by 
Fung given that the theory of viscoelasticity was much more difficult to implement than the 
theory of elasticity (Fung 1990).  
  
Equation ‎2-1 
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For a hyperelastic material: 
    
  
    
  
  
    
 
where:  
   = components of the second Piola-Kirchhoff stress tensor 
   = components of the Green-Lagranian strain tensor 
    components of the right Cauchy-Green deformation tensor   
Several forms of strain energy functions have been proposed to fit experimental stress-strain 
data obtained for different materials given that each function is suitable for certain material 
behaviours. To describe the stress-strain relationship of arteries Fung (1990) employed an 
exponential strain energy function of the form: 
                                                        
 
 
       ; 
                                                              
 +     
       
  
                                        
                                                            
where c and       are material parameters obtained by fitting to the experimental stress-
strain data and         are the components of the Green-Lagrangian strain tensor. Fung 
(1990) showed that this strain energy density function could be used to obtain reasonable fits 
to data for various soft tissues including myocardium, arteries and skin.  
In addition polynomial forms of the strain energy functions have been widely used to model 
soft tissues and biomaterials. An example of a widely used polynomial strain energy function 
for arterial tissue is the Mooney-Rivlin model, proposed by Mooney (1940) with its general 
form shown below: 
Equation ‎2-4 
 
Equation ‎2-2 
 
Equation ‎2-3 
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where     are material constants, and           are stretch invariants for the material as 
follows: 
Equations ‎2-5 
                                                
and      for incompressible materials. In addition many polynomial strain energy density 
functions have been proposed and used to model hyperelastic materials which are formulated 
based on the principal stretches. The most widely used of such functions for arterial tissue, 
given its good capability to fit to different materials stress-strain data, is the model proposed 
by Ogden (1984) in the following form: 
Equation ‎2-6 
where    and    are material constants. All the models discussed above are 
phenomenological models, meaning that they are just mathematical equations that can be 
derived by fitting to the experimental stress-strain data of the materials. Although the Ogden 
model is highly capable of fitting to stress-strain data obtained from soft tissue and rubber like 
materials, it is very important to determine the hyperelastic constants with high precision 
since the model response is highly sensitive to the constants and small changes in the number 
of significant digits may dramatically alter the model behaviour (Ogden et al., 2004). 
An alternative approach in soft tissue biomechanics is the mechanistic models which are 
informed by the structure of the material and study the tissue as a heterogeneous material. In 
this sense the parameters used in these models are not merely curve fitting constants and 
have physiological meaning. One prominent example of such a model is the model proposed 
by Holzapfel (2000b) which treats the arterial wall as a heterogonous material composed of a 
homogeneous ground matrix and two families of collagen fibres dispersed in the matrix at a 
specific angle and symmetric with respect to one another. Given that the model considers the 
presence of two families of collagen fibres, the model can capture the anisotropy of the 
arteries, see Figure 2-11. 
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Figure ‎2-11: A schematic of the collagen fibre orientation in the constitutive model 
developed by Holzapfel et al., (2000b) depicting the two families of collagen fibres and their 
helical orientation in the artery. 
Holzapfel (2000b) accounted for the presence of the fibres in the ground matrix using a 
decoupled formulation for the isochoric (non-volume changing) strain energy function 
composed of two terms as follows: 
Equations ‎2-7 
 
where    and   
  are the directions of collagen fibres present in the artery and C is the right 
Cauchy-Green strain tensor. Holzapfel then defined the strain energy function of the ground 
matrix using a simple neo-Hookean formulation and the strain energy stored in the collagen 
fibres using an exponential formulation as follows: 
Equations ‎2-8 
 
 
where                   are material constants. 
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In order to apply the aforementioned models or any similar ones for arterial tissue or similar 
biomaterials such as a vascular scaffold or graft (which ideally should have artery-like 
hyperelastic properties), the material constants have to be determined based on experimental 
tests. A strain energy density function should then be chosen which can best fit the stress-
strain data of the material and satisfy the convexity condition of the strain energy function to 
assure stability of the model. 
2.3.2 Finite element modelling of vascular devices 
As discussed previously, reducing the risk of injury in the arterial wall is a key aspect of stent 
design. Computational models of stent deployment, such as FE models, are excellent tools for 
optimisation of stent designs and can be used along with experimental studies to improve the 
mechanical performance of stents by reducing the injury level in the arterial wall. In addition 
to being cost effective, computational models often offer the only solution to address some of 
the important challenges influencing stent design such as the estimation of stresses induced in 
the vessel wall and therefore the degree of vascular injury.  
FE models of stent expansion enable quantification of the stress-strain field in the stents and 
also in the vessel wall following stent deployment and therefore provide insights into the 
various aspects of stent design that may reduce the risk of arterial injury.  
One important advantage of computational models of stent deployment over in-vivo studies is 
that they enable the influence of the mechanical parameters of interest to be studied in 
isolation, while due to the several complex and intertwined biological, chemical and 
mechanical factors involved in-vivo, it is often difficult to associate the outcome of an in-vivo 
trial to one specific mechanical factor and further proceed to rectify that by optimising the 
stent design. A good example of this is the influence of stent strut thickness on in-stent 
restenosis. In recent years, several clinical trials have identified stent strut thickness as an 
independent predictor of restenosis (Kastrati et al., 2001; Briguori et al., 2002; Pache et al., 
2003). A clear conclusion from the many clinical studies on stent strut thickness is that stents 
with thinner struts have a lower restenosis rate, consequently, most of the current generation 
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of stents are produced with thinner struts using high strength materials such as cobalt–
chromium alloys (Morton et al., 2004). The ISAR-STEREO clinical trial focussed on the influence 
of stent strut thickness and compared the restenosis outcome for two stents with the same 
design but different strut thickness (Kastrati et al., 2001). Although the study highlights the 
importance of stent strut thickness, it does not clearly elucidate the role and significance of the 
mechanisms by which stent strut thickness could lead to the higher restenosis rate.  
From a mechanical perspective the effect of stent strut thickness can be twofold: (i) from a 
solid mechanical viewpoint where stresses induced in the artery are concerned, and (ii) from a 
hemodynamic viewpoint where blood flow perturbations due to strut thickness are concerned. 
In-vitro studies may not address each of these separate factors in isolation. Also several 
biological factors are involved in-vivo, such as the higher metal surface exposed to blood flow 
in thicker strut stents to which platelets can adhere and produce mitogenic growth factors, 
which make studying the role of a mechanism of interest extremely difficult. In contrast, 
computational models enable each different parameter involved in such a complex process to 
be studied in isolation. For instance, Duraiswamy et al., (2007) studied the influence of stent 
strut thickness from a hemodynamics perspective and quantitatively showed that thicker stent 
struts lead to significantly larger recirculation zones and altered shear stress pattern in the 
vicinity of struts which can contribute to restenosis. In this context, FE simulations of stent 
deployment procedures can also be used to clarify the influence of stent strut thickness on the 
vessel wall stresses and provide enlightening guidelines for stent design.  
Stent strut thickness is just one of the many factors involved in the stent design and the use of 
finite element method (FEM) is not limited to this factor. FEM can be utilised to study a wide 
range of design parameters in order to reduce arterial injury. Several studies have investigated 
the mechanical response of stents using the FEM and have suggested different strategies for 
their simulation (Lee et al., 1992; Rogers et al., 1999; Auricchio et al., 2001; Prendergast et al., 
2003; Holzapfel et al., 2005b; Lally et al., 2005; Migliavacca et al., 2005, 2007; Wang et al., 
2006; Gijsen et al., 2008). Given the difficulties involved in construction of the model geometry 
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and the complex contact problem involved in the interaction of a balloon, stent and artery, 
many simplified methods have been used to model the complex mechanics of stent 
deployment. Balloons used for stent deployment are initially in a folded configuration. As the 
balloon unfolds it appears highly compliant however as its unfolded shape is reached the 
balloon becomes highly noncompliant. This complex procedure of balloon unfolding is difficult 
and very computationally expensive to model. 
Four main strategies have been used in the literature for numerically modelling balloon 
expansion of stents which include; (i) direct application of a uniform pressure to the stent 
luminal surface (Dumoulin and Cochelin 2000; Migliavacca et al., 2005; De Beule et al., 2006; 
Early et al., 2008), (ii) a rigid cylinder expanded by application of radial displacement  (Hall and 
Kasper 2006; Takashima et al., 2007; Wu et al., 2007), (iii) stent deployment using a folded 
balloon model (De Beule et al., 2008; Gervaso et al., 2008) and (iiii) pressurisation of simple 
elastic cylinders with hyperelastic material properties neglecting the balloon folds (Ju et al., 
2008; Kiousis et al., 2009).  
Gervaso et al., (2008) compared the first three strategies and concluded that a folded balloon 
model is necessary for accurate estimation of mechanical stresses. In spite of this, the 
computational costs and the effort involved in modelling folded balloons has urged many 
researchers to resort to alternative strategies which disregard the balloon model. In this 
context, Early et al., (2008) proposed a method of stent expansion by direct application of a 
uniform pressure on the inner stent surface in conjunction with special function elements 
connected to the stent nodes which restrained stent expansion as the desired expansion 
diameter was achieved. However, no comparison with stent deployment using folded balloons 
was presented to fully support the use of this method and to elucidate its limitations. Although 
such a modelling strategy can significantly reduce the computation time and the effort 
involved in construction of a balloon model, the conditions under which it can yield accurate 
results is not well studied and the limitations of this method remain to be investigated.  
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On the other hand in the context of vascular grafts, FE modelling can help ensure compliance 
matching of vascular grafts with different host arteries. Given the availability of constitutive 
models for most host arteries in the literature, constitutive models for graft materials can be 
established by mechanical characterisation tests and implemented in FE models to optimise 
design variables such as material properties and geometrical parameters in order to ensure 
compliance matching of the grafts with different host arteries, reduce the risk of failure in the 
graft and also minimise stresses and therefore injury in the host arteries (Steinman 2003).  
2.3.3 Mechanobiological modelling of vascular devices 
The daunting complexities of biomechanical systems have motivated tremendous efforts 
towards developing novel computational models for predictive purposes and also to provide 
better understanding about these systems.  
One important potential of computational models is that they enable the hypotheses about 
complex biological systems to be corroborated or refuted and hence constantly add to our 
knowledge about them (Nigg & Herzog 2001; Viceconti 2010). Computational models of the 
biomechanics of the skeletal system and cardiovascular system have significantly advanced in 
the recent years and have constantly added to our knowledge of the role of biomechanics 
ranging from progression of pathological conditions such as skeletal deformities (Subbaraj 
1989), development of aneurysms (Watton et al., 2009), fracture and wound healing (Geris et 
al., 2010a; Geris et al., 2010b), and stent implantations and its prognosis (Caiazzo et al., 2009; 
Zahedmanesh et al., 2009; Boyle et al., 2010; Zahedmanesh et al., 2010).  
One important complexity which is specific to biomechanical systems is their regenerative 
ability to adapt their structure and properties in order to maintain homeostasis following any 
mechanical or biological perturbations. In many cases, however, this regenerative response of 
the biomechanical systems may derail into a maladaptive response. In-stent Restenosis 
following stent deployment (Hoffman et al., 2000) and development of intimal hyperplasia (IH) 
following implantation of small calibre vascular grafts (Lemson et al., 2000; Salacinski et al., 
2001; Zilla et al., 2007) are examples of such maladaptive responses. In this context the global 
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response of the biological system which emerges at the tissue level as excessive luminal 
ingrowth stems from individual cell behaviour and interaction among cells. Cellular behaviours 
such as differentiation, proliferation, migration, protein and chemokine synthesis and cell 
death are influenced by the environmental factors such as extracellular matrix, chemicals, and 
forces and add up to emerge as complex responses at the tissue level. This intrinsic multi-scale 
behaviour of biological systems necessitates a multi scale modelling approach. 
Two main approaches have been taken for modelling the response of multi cellular biological 
systems, (i) the continuum approach and (ii) the cell-based Approach (Byrne et al., 2009). The 
continuum approach can be used to model the response of biological systems at all levels from 
cells to tissue. Although key cell responses such as cell density evolution can be modelled using 
partial differential equations (PDEs), one important limitation of this method is that PDEs may 
not capture the discrete nature of multi cellular biological systems consisting of individual cells 
and can become cumbersome when solving complex processes involving several variables 
(Hwang et al., 2009). The other method used for modelling the response of multi cellular 
biological systems is the discrete approach. The global behaviour of a biological system results 
from discrete phenomena occurring at the cellular level, hence biological systems may be 
better modelled using discrete methods.  
Two main discrete methods have been used for modelling the multi cellular biological systems, 
namely (i) Cellular Automata (CA) and (ii) Agent Based Models (ABM). Both methods can be 
defined as rule based models that take a bottom up approach. Each individual cell is modelled 
explicitly based on the rules of behaviour which are defined for it and the global system 
behaviour emerges through the local interactions among the cells based on the defined rules 
of behaviour at the cell level. Although the differences between (CA) and (ABM) are marginal, 
the main difference is that a lattice point needs to be defined for (CA) while (ABM) can be 
lattice free, meaning that cells can be at any location in the computational domain. This 
location is usually determined by solving either kinematic or dynamic equations of motion for 
each individual cell. Hence (ABM) can yield more realistic results given that no restriction is 
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imposed on the location of the cells in comparison to (CA) where the cells can only move 
through certain predefined lattice points. A hybrid modelling approach may be also adopted by 
combining both continuum and discrete methods (Gerlee et al., 2008; Guo et al., 2008).  
With the emergence of tissue engineering as a promising technique in regenerative medicine, 
there is a genuine need for robust mechanobiological models for analysis of tissue engineered 
constructs. Tissue engineers need to consider a wide range of variables ranging from the type 
of scaffold material and its mechanical and morphological properties such as elasticity, 
porosity and permeability, to the best choice of cells and the optimum bioreactor parameters, 
such as the loading regime, to obtain a functional tissue engineered construct. In the context 
of vascular tissue engineering, and specifically in the case of low calibre vessels, complexities 
arise mainly due to development of IH where vascular smooth muscle cells (VSMCs) over-
proliferate into the lumen of the construct and ultimately occlude the blood flow.  
Optimally a vascular scaffold should allow the vascular cells to populate the scaffold and 
remodel it into a tissue similar to the artery by producing extra-cellular matrix components; 
however, it should prevent over-proliferation of cells towards the lumen. IH in vascular grafts 
and tissue engineered blood vessels (TEBVs) occurs due to an imbalance between inhibitory 
and proliferative mechanisms which control the growth of VSMCs. Scaffold properties such as 
porosity and permeability are vital to ensure nutrient transport and waste removal in a TEBV. 
On the other hand, the elasticity of the construct, usually measured as compliance in the 
context of vascular grafts/scaffolds, plays a pivotal role in vascular scaffold remodelling as 
cyclic strain has a significant anti-proliferative and pro-apoptotic influence on VSMCs (Colombo 
2009). In addition, fluid flow in a scaffold is influenced by cyclic strain (Buijs et al., 2009) and is 
therefore also dependant on the elasticity of the scaffold when it is subject to pulsatile 
pressure in the arterial system. The importance of the role of compliance is further supported 
by the outcome of vascular graft implantations which suggest a direct relation between the 
compliance of vascular grafts and their long term patency (Salacinski et al., 2001).  
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Another key factor in regulating the proliferative response of VSMCs, is a functional 
endothelium. In the absence of a functional endothelium, inflammatory cells such as 
macrophages and platelets are recruited to the lumen of the scaffold/graft and secrete 
mitogenic and chemotactic factors such as Platelet Derived Growth Factor (PDGF) which have 
a proliferative influence on VSMCs (Lemson et al., 2000). However, to date most available 
vascular grafts/scaffolds have shown a very poor endothelialisation rate in the human body 
(Zilla et al., 2007). Given the central role of VSMCs in success or failure of TEBVs, it is necessary 
to better understand the mechanobiological mechanisms which regulate VSMC growth 
dynamics in vascular tissue engineered constructs and mechanobiological models can be 
utilized for this purpose.  
Several mechanobiogical models have been developed using the continuum approach    
(Coletti et al., 2006; Andreykiv et al., 2008; Issaksson et al., 2008) and also the cellular 
automata approach (Byrne et al., 2007; Stops et al., 2010) combined with robust numerical 
methods such as the FEM. However, in spite of the significant role of mechanoregulation in 
vascular tissue engineering (Seliktar et al., 2003; Jeong et al., 2005; Hahn et al., 2007; Xu et al., 
2008) and the central role of VSMCs in this context, mechanobiological models of VSMC tissue 
engineered constructs are scarce and the available mechanobiological models are mainly 
focused on skeletal tissue engineering and fracture healing.  
On the other hand, even though lattice free agent based models have been extensively used in 
modelling multicellular biological systems (Walker et al., 2004; Baily et al., 2007; Thorne et al., 
2007; Merks et al., 2008; Li et al., 2008; Pappalardo et al., 2009), these models are merely 
biological and mechanoregulation is rarely included to these studies. The few 
mechanobiological models which have used lattice free agent based models have resorted to 
calculation of the mechanical stimuli (i.e. stress/strain) using simple analytical equations rather 
than using more robust numerical methods such as FEM (Peirce et al., 2004; Ausk et al., 2006; 
Geris et al., 2010c). This is mainly due to the fact that lattice free agent based models are 
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computationally expensive and coupling them with numerical methods such as FEM is 
challenging. 
Given that cyclic strain due to pulsatile blood pressure is the prevalent mechanical load that 
VSMCs are exposed to in an artery, several studies have been dedicated to the study of the 
influence of cyclic strain on VSMCs (Chapman et al., 2000; Durante et al., 2000; Morrow et al., 
2005; Wang et al., 2006; Colombo et al., 2009). It has been shown that physiological cyclic 
strain (less than 15% amplitude) has an anti-proliferative influence on VSMCs and also 
increases the apoptosis rate of VSMCs (Chapman et al., 2000; Morrow et al., 2005; Colombo et 
al., 2009; Kona et al., 2009).  
In a recent in-vitro study by Colombo (2009) which was dedicated to the study of the role of 
cyclic strain on VSMCs, bovine aortic SMCs were cultured under cyclic strain with varying mean 
and amplitude. The study concluded that physiological cyclic strain has an anti-proliferative 
influence on VSMCs and that the relationship between cyclic strain and proliferation and 
apoptosis rate depends on the amplitude of the cyclic strain rather than on the mean value of 
the cyclic strain. The consistency of these findings on human VSMCS was also verified by 
conducting the same experiments on human Iliac SMCs (Colombo 2009). Conversely, 
pathological values of cyclic strain (>15%) have been found to play a conflicting role and 
increase proliferation in VSMCs (Numaguchi et al., 1999; Kozai et al., 2005; Halka et al., 2008; 
Kona et al., 2009).  
In addition, physiological cyclic strain has been shown to upregulate synthesis of ECM products 
such as collagen and Elastin (Kona et al., 2009). On the other hand pore fluid velocity within a 
tissue engineered construct can significantly improve nutrient delivery and waste removal 
which in turn increases the proliferation rate and reduces cell death. Cartmell et al., (2003) 
studied the effect of medium perfusion rate on cell growth and ECM synthesis within human 
trabecular bone scaffolds seeded with osteoblast-like cells and showed a significant increase in 
DNA content in perfused samples compared to statically grown samples. In another study by 
Volkmer et al., (2008) cell death occured in the central region of a statically cultured bone 
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matrix scaffolds following 5 days culture, whilst in contrast, perfusion bioreactors successfully 
prevented cell death in the scaffold. Culture of VSMCs on vascular scaffolds have also resulted 
in a higher number of VSMCs and improved mechanical properties when cultured in perfusion 
bioreactors compared to the static culture (Jeong et al., 2005; Stankus et al., 2006; Hahn et al., 
2007). Therefore from a mechanobiological modelling stand point, cyclic strain and pore fluid 
flow are two key mechanical regulators of VSMC growth in a vascular tissue engineered 
construct which have to be given specific consideration.  
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2.4 Summary 
Several biomechanical factors are involved in the design and application of vascular devices. In 
this context, stents and vascular grafts need to be given specific attention as they are the two 
key devices widely used in the treatment of cardiovascular disease. In order to improve the 
performance and outcome of stents and vascular grafts, however, the following crucial 
biomechanical challenges remain to be more fully understood and quantifiable:  
 Arterial Injury due to high stresses conferred to the arterial wall following stent 
deployment which is considered to be the main cause of in-stent restenosis.  
 Mechanical compliance mismatch of vascular grafts with that of host arteries which 
leads to development of intimal hyperplasia and consequent loss of patency 
specifically in low calibre arteries (<6mm diameter).  
 The growth and remodelling of vascular tissue engineered blood vessels which is highly 
dependent on mechanical factors such as mechanical properties of the scaffold and 
external mechanical stimulation.    
Computational modelling is a robust and efficient platform to develop new strategies and 
designs in order to overcome the aforementioned challenges. Computational modelling of 
stent deployment is the only possible method to precisely quantify the stresses induced in the 
arterial wall and therefore the risk of arterial injury due to stent deployment. As a result, FE 
models of stent deployment are widely used for design optimisation and as a preclinical testing 
platform to improve the performance of stents by reducing the risk of injury to the arterial 
wall. However, FE simulations of stent deployment are computationally expensive and it is 
therefore necessary to investigate the different modelling strategies to determine an optimal 
strategy which offers the lowest computational cost combined with high accuracy. In Chapter 
3, different modelling strategies are investigated and Chapter 4 proceeds to showcase the 
application of the optimal modelling strategy determined in Chapter 3 to investigate the 
influence of stent strut thickness on the arterial wall stress levels. 
41 
 
On the other hand, in the case of vascular grafts, FE models can be used to ensure compliance 
matching of vascular grafts with different host arteries. Given the availability of constitutive 
models for most host arteries in the literature, constitutive models for graft materials can be 
established by mechanical characterisation tests and implemented in patient specific FE 
models to optimise design variables such as material properties and geometrical parameters in 
order to build vascular grafts custom-tailored to match any specific artery and patient. Such a 
procedure will minimise intimal hyperplasia and will prevent graft rupture and arterial injury 
due to high anastomotic stresses. Chapter 5 is therefore used to showcase how mechanical 
characterisation experiments can be conducted in order to develop constitutive models that 
can be used in FE modelling of vascular grafts to predict their mechanical behaviour in-situ. In 
this context, bacterial cellulose as a novel biomaterial was deemed to be a suitable candidate 
and therefore the method was specifically applied to bacterial cellulose tubes.  
Also computational models can be used in vascular tissue engineering to decipher the 
important role that mechanical factors i.e. scaffold mechanical properties and external 
mechanical stimulation play in regulating the growth dynamics of VSMCs and remodelling of 
the scaffolds. Such a model can be used as a tool to optimise the mechanical properties of 
vascular scaffolds and pinpoint an optimal in-vitro mechanical stimulation regime that would 
enhance remodelling and prevent intimal hyperplasia. However to-date, no such 
computational study dedicated to development of a mechanobiological model for vascular 
tissue engineering applications exists. In Chapter 6, therefore, a novel mechanobiological 
modelling framework is presented that addresses this challenge. 
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3 Chapter 3                                                                                                     
Simulation of a balloon expandable stent in a realistic coronary 
artery; Determination of the optimum modelling strategy 
Computational models of stent deployment in arteries have been widely used to shed light on 
various aspects of stent design and optimisation. In this context, modelling of balloon 
expandable stents has proved challenging due to the complex mechanics of balloon-stent 
interaction and the difficulties involved in creating folded balloon geometries. In this study, a 
method to create a folded balloon model is presented and utilised to numerically model the 
accurate deployment of a stent in a realistic geometry of an atherosclerotic human coronary 
artery. Stent deployment is, however, commonly modelled by applying an increasing pressure 
to the stent, thereby neglecting the balloon. This method is compared to the realistic balloon 
expansion simulation to fully elucidate the limitations of this procedure. An alternative balloon 
simulation procedure is also presented to overcome many of the limitations of the applied 
pressure approach by using elements which restrain the stent as the desired diameter is 
achieved.  
3.1 Materials and methods 
A FE model of a patient specific atherosclerotic coronary artery and the ACS Multi-Link RX 
DUET stent was constructed and the stent was expanded within the artery using three 
different strategies as defined by the following case studies:  
i) A uniformly increasing pressure, to a maximum value of 16 atm, was directly 
applied to the inner stent surface.  
ii) A uniformly increasing pressure was directly applied to the inner stent surface to 
achieve an inner stent diameter equal to the fully expanded balloon (3.5mm) in 
conjunction with connector elements which restrained the stent expansion 
beyond this diameter. One end of these connector elements was connected to the 
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nodes on the stent outer surface and the other end was connected to the ground 
(i.e. the initial coordinates of the same node prior to deformation).   
iii) Expansion of the stent using a realistic three-fold balloon inflated to a diameter of    
3.5 mm using a maximum pressure of 16 atm. 
To generate the simulations pertaining to each case study, the FE models require a number of 
inputs: namely the geometry of the stent, the atherosclerotic coronary artery, and the three-
fold balloon; the material properties of the stent, artery and balloon; and the appropriate 
application of loading and boundary conditions, as described below. 
3.1.1 Model Geometry 
A patient derived model of an aged atherosclerotic human coronary artery was constructed 
based on digitised 3D angiography images provided by the 3D imaging laboratory, Division of 
Cardiology, School of Medicine, University of Colorado, USA. The images were obtained using a 
method developed and described by Messenger et al. (2001) to obtain an accurate 3D 
geometry of the lumen of an atherosclerotic artery. The vessel wall dimensions were 
generated based on assigning a healthy arterial wall thickness of 0.5 mm at the proximal end 
of the vessel, upstream from the stenosed region, by offsetting the lumen contour by 0.5 mm. 
This outer diameter was then extrapolated across the stenosed region of the vessel to define 
both healthy vessel wall and atherosclerotic plaque regions. The model was subsequently 
meshed using ANSYS (Canonsburg, PA, USA) assigning 6 elements through the thickness of the 
healthy artery wall and three elements through the plaque thickness. The vessel was divided 
into three layers; intima, media, and adventitia. The thickness of each arterial layer was 
discretised by two elements and the thickness of each layer was assigned using ratios of 
adventitia, media and intima to the wall thickness of 0.38, 0.33, and 0.29 respectively 
consistent with the data reported by Holzapfel et al., (2005a). Eight node linear brick, reduced 
integration elements with hourglass control (ABAQUS element type C3D8R) were used to mesh 
the atherosclerotic coronary artery. The total number of elements used to mesh the 
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atherosclerotic coronary artery was 29,400 which was chosen based on mesh sensitivity 
studies (see Appendix A-A.1). All elements were checked to ensure that no distorted elements 
were generated. In addition, element distortion control was used to prevent inaccuracies 
arising from excessive distortion of elements in the contact regions. 
A full three-dimensional FE model of the stent was generated and meshed in ANSYS based on 
the ACS MultiLink RX Duet manufactured by Guidant/Advanced Cardiovascular Systems. The 
stent has an interconnected-ring design, struts with rectangular cross-sectional areas and 
width and thickness of 100 μm and 140 μm, respectively. The length of the stent was 15 mm 
consisting of seven rings in the longitudinal direction with six crowns in each ring. The stent 
inner radius in the crimped configuration was 0.72 mm, with a corresponding outer radius of 
0.86 mm. The stent dimensions were extrapolated from the handbooks of coronary stents 
(Serruys et al., 1998; Serruys et al., 2000).  
To generate the stent model, a procedure previously reported by Lally et al., (2005) was 
adopted. The stent geometry was initially modelled in an opened-out, planar configuration 
utilising a Cartesian coordinate system. The volume of the stent was discretised by eight node 
linear brick, reduced integration elements with hourglass control (ABAQUS element type 
C3D8R). The model of the stent was meshed with two elements through the thickness and a 
total number of 30,768 elements which was opted based on mesh sensitivity studies. Finally, 
the nodal coordinates of the meshed model were transferred from the Cartesian coordinate 
system into a cylindrical coordinate system where the planar configuration was wrapped to 
generate the cylindrical structure of the stent.  
In order to create the geometry of a three-fold crimped balloon, the geometry of a fully 
expanded balloon was generated in ProEngineer (Needham, MA, USA) with a diameter of 3.5 
mm and was exported into ABAQUS (SIMULIA, Providence, RI, USA). The imported geometry 
was meshed using 4-node doubly curved shell elements with reduced integration and 
hourglass control, (ABAQUS element type S4R). The balloon was then deflated in an explicit 
simulation by application of a negative pressure of 0.01 MPa on its inner surface using general 
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contact and with the proximal and distal ends fully constrained. Symmetry boundary 
conditions were applied on the balloon nodes at every 120 degrees in the circumference using 
the CONSTRAINTS command in ABAQUS so as to deflate the balloon into a tri-wing 
configuration. Later the wings were folded circumferentially onto one another in a subsequent 
step by application of pressure to one side of each wing while the base of each wing was fully 
constrained in order to generate the three-fold crimped balloon configuration, see Figure 3-1.  
 
   
 
Figure ‎3-1: The process of creating the three-fold balloon geometry. 
  
Application of negative 
pressure on the inner 
balloon surface (P<0) 
Tri-wing configuration of 
the balloon 
Folding the wings  
Crimped balloon 
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3.1.2 Material Properties 
Layer specific human coronary arterial wall properties were assigned to the artery, consisting 
of the intima, media and adventitia based on the data from Holzapfel et al., (2005a). Human 
cellular atherosclerotic intimal plaque properties were assigned to the localised plaque based 
on the available published data from Loree et al., (1994). The material of the intima, media and 
adventitia and plaque were defined using Ogden hyperelastic constitutive equations (Ogden 
1972): 
Equation ‎3-1 
Where     denotes the deviatoric principal stretches,   is the elastic volume strain and   ,    
and    are the hyperelastic constants, and N represents the order of the equation. 
The constitutive equations were determined by fitting to the circumferential stress-strain data 
of human coronary artery as published in Holzapfel et al., (2005a) and the tensile stress-strain 
data of cellular atherosclerotic plaque published in (Loree et al., 1994).   
A non-linear regression routine, available in ABAQUS, was used to obtain the constitutive 
models that best fit the experimental data. The stability of the material constitutive models 
was checked using the routine available in ABAQUS. The hyperelastic coefficients used for 
artery/plaque models are summarized in Table 1.  The arterial components and atherosclerotic 
plaque were assumed to be nearly incompressible. This assumption was imposed by specifying 
a Poisson’s ratio of 0.49, infinitesimal values for D1, and zero for D2 and D3 in the hyperelastic 
constitutive equations describing the materials, see Table 3-1.    
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Table ‎3-1: Coefficients of the Ogden hyperelastic constitutive models (Zahedmanesh and 
Lally 2009) 
 
The stress-strain response of the stent was applied based on data from a study by                  
Murphy et al., (2003) on the mechanical behaviour of the 316L stainless steel stent struts. The 
linear elastic response of the material was described as an isotropic material with a Young’s 
Modulus of 196 GPa and Poisson’s Ratio of 0.3. A piecewise linear function was used to 
represent the non-linear plasticity through a von Mises plasticity model with isotropic 
hardening.  
The balloon was modelled as an isotropic, linear-elastic material, with a Young’s modulus of 
900 MPa and Poisson’s Ratio of 0.3 based on the data published by Gervaso et al., (2008). 
3.1.3 Boundary Conditions 
 The two ends of the coronary artery were tethered using connector elements which were 
assigned elasticity characteristics. One end of these elements was connected to the end nodes 
of the artery and the other end was connected to the ground. The elasticity of these elements 
was chosen to be 1000 N/m which assured that the ends of the artery were constrained.  
The load used for the expansion of the stents in case study (i) and (iii) was 16 atm which was 
applied on the inner surface of the stent and the inner balloon surface, respectively. This value 
is the maximum clinically permissible pressure for the expansion of most stents (Serruys et al., 
Ogden hyperelastic model 
constants 
Intima Media Adventitia Plaque 
µ1 (Pa) -7’037’592.77 -1’231’144.96 -1’276’307.99 93’726.43 
µ2 (Pa) 4’228’836.05 875’118.59 846’408.08 - 
µ3 (Pa) 2’853’769.62 453’616.46 438’514.84 - 
α1 24.48 16.59 24.63 8.17 
α2 25.00 16.65 25.00 - 
α3 23.54 16.50 23.74 - 
D1 8.95 x 10
-7 5.31 x 10-6 4.67 x 10-6 4.30 x 10-7 
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1998, 2000). However in case study (ii) a maximum load of 30 atm was applied to the stent 
inner surface to fully expand the stent to a diameter equivalent to the diameter achieved using 
the balloon model. Restraining connector elements were applied to every node of the stent 
however to ensure that the diameter of stent did not exceed the desired diameter due to the 
application of this clinically meaningless pressure of 30 atm.  
All of the restraining connector elements were attached to ground and assigned a length of    
1.113 mm to ensure that the stent expanded from its crimped state to a final expansion 
diameter of 3.5 mm.  Given that the stent is symmetric in the circumferential direction the two 
ends of the restraining connector elements could have been connected between 
circumferentially symmetric nodes of the stent. However in many cases stents are not 
symmetric in the circumferential direction and therefore one end of the connector elements 
must be connected to the ground while the other end is connected to the stent nodes. In this 
study although the stent is circumferentially symmetric, in order to maintain the generality of 
the approach, one node of each of the connector elements was always connected to the 
ground.  
In order to model the adhesion of the balloon to the catheter in case study (iii), the two end 
nodes of the balloon were connected using a connector element which was assigned a 
maximum length equal to the balloon length in the folded configuration and  allowed for 
possible balloon bending. In addition the end nodes of the balloon were constrained in the 
tangential direction.   
The general contact available in ABAQUS explicit was used to model the contact between the 
stent, balloon, and artery using frictionless contact with the default properties in all models. In 
addition, in all of the case studies three circumferentially symmetric nodes in the middle of the 
stents were constrained in the axial direction. 
ABAQUS explicit was used in this study given its robust general contact algorithm and its ability 
to handle highly deformable materials well. However, when performing a quasi-static analysis 
using the explicit approach it is vital to ensure that the inertial forces are negligible throughout 
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the simulation and do not cause unrealistic dynamic effects. Therefore, in this study the ratio 
of kinetic energy to the total strain energy was consistently maintained lower than 5%. This 
criterion was proposed by Kim et al., (2002) and ensures that the dynamic effects are 
negligible. In order to respect this criterion the simulation times were set to three seconds in 
all case studies. 
3.2 Results 
The method proposed in this study to create the three-fold balloon geometry combined with a 
patient derived model of the coronary artery in case study (iii) enabled a realistic simulation of 
the stent deployment, see Figure 3-2.  
 
 
 
Figure ‎3-2: Assembly of layer specific stenosed coronary artery, stent and balloon in the (a) 
crimped configuration prior to expansion, (b) dog-boned configuration upon pressurisation 
(c) following full expansion. The adventitia, media, intima, and the atherosclerotic plaque 
are represented by green, blue, red and grey respectively. 
(a) 
(b) 
(c) 
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Stent deformation response in this case study showed significant differences when compared 
with the results obtained from case studies (i) and (ii). The deformation of the stent was 
investigated by studying the pressure-expansion response, flaring of the stent widely known as 
dog-boning and foreshortening which represents the shortening of the stent length.  
 According to Kiousis et al., (2009) the dog-boning of the stent may be defined using the 
following ratio: 
 
Equation ‎3-2 
 
and the foreshortening of the stent may be defined as: 
 
Equation ‎3-3 
Where Ddistal and Dcentral represent the diameter at distal and central locations of the stent 
and Ldeformed and Lundeformed represent the deformed and undeformed length of the stent 
respectively.  
In all case studies, dog-boning occurred upon pressurization, however in case study (iii) where 
the stent was expanded using a balloon model, the dog-boning was more pronounced and 
initiated at a lower pressure.  The maximum dog-boning percentage in case study (iii) reached 
49% at a pressure of 4 atm. In contrast, in case study (i) and (ii) this value reached a maximum 
of 19% at a pressure of 14.4 atm. The final dog-boning after stent recoil however was identical 
in case studies (ii) and (iii) with a value of 6%. This value was found to be 19% for case study (i), 
see Figure 3-3. 
The overall pressure-diameter response in the mid-stent region in all case studies was 
determined as a function of pressure, see Figure 3-4.  
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Figure ‎3-3: Dog-boning of the stent as a function of the applied pressure throughout the 
deployment process. 
 
 
 
Figure ‎3-4: Pressure–diameter relationship of the stent throughout the deployment process. 
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Comparison of the curves illustrates a significantly different pressure-expansion response in 
case study (iii) in which the stent-balloon assembly showed a highly compliant response as the 
pressure reached 4 atm and the diameter increased rapidly from 1.5 mm to 3 mm, see Figure 
3-4. This highly compliant response cannot be generated using direct application of a uniformly 
increasing pressure. A similar response consistent with the results of case study (iii) has 
previously been reported in experimental studies of stent deployment (Migliavacca et al., 
2008; Kiousis et al., 2009). 
The most significant difference in the stent deformation pattern, however, was found in the 
foreshortening curves, see Figure 3-5.  
 
 
 
Figure ‎3-5: Foreshortening of the stent as a function of applied pressure throughout the 
deployment process. 
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Case study (iii) shows a foreshortening response with negative values at all pressures reaching 
a maximum foreshortening of -10% at a pressure of 5.6 atm. In contrast the foreshortening 
response in the other case studies takes positive values over a wide range of pressures with a 
maximum value of +8% in case study (ii). Clearly, direct application of uniform pressure on the 
stent inner surface in case studies (i) and (ii) leads to elongation of the stent in the 0 to 15 atm 
pressure range. On the contrary, expansion of the stent using the balloon model predicts 
shortening of the stent in the longitudinal direction which is consistent with the findings of 
experimental studies on very similar stents (Kiousis et al., 2009).  
Exploring the stresses in the vessel wall showed that the highest stresses occurred in the 
plaque and intima. In case studies (ii) and (iii) the von Mises stresses induced in the arterial 
tissue were of very similar magnitudes with maximum values of approximately 950 kPa and 
170 kPa in the plaque and intima, respectively, and the predicted stress fields were 
comparable, see Figure 3-6. Comparison of the maximum stresses in case studies (i) and (iii), 
however, revealed  the maximum von Mises stresses in the plaque and intima to be almost 
65% lower in case study (i), see Figure 3-6. Moreover, the percentage of the tissue volume 
stressed over a certain threshold, to the total volume of the tissue, was calculated based on 
the stress value at the element integration points and quantifying the volume of plaque and 
intima tissue stressed at high levels within the vessel also proved very similar in case studies 
(ii) and (iii), see Figure 3-7. 
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Figure ‎3-6: Von Mises Stresses in the stenosed vessel (a) applying uniform pressure to the 
stent, case study (i), (b) applying uniform pressure to the stent using restraining elements, 
case study (ii) and (c) using the balloon model, case study (iii). 
 
Figure ‎3-7: Percentage volume of plaque tissue stressed above 500kPa and of intimal tissue 
stressed above 50kPa using uniform pressure with restraining elements (Black) and a folded 
balloon (Grey). 
In addition, investigating the stresses in the stent, a maximum von Mises stress of 761 MPa 
was found in the stent expanded using the balloon which is 4% and 10% higher than that 
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base of the crowns where the crown joins the longitudinal struts and also in the crown tips in 
all cases.  
3.3 Discussion 
Simulation of stent expansion by direct application of pressure to the stent inner surface has 
been widely used in the literature as a means of reducing the computational costs of modelling 
the deployment of balloon expandable stents (Lally et al., 2005; Early et al., 2008; Gijsen et al., 
2008). Discarding the balloon model from the simulation reduces the contact problem from 
stent-artery and stent-balloon contact pairs to only a stent-artery contact problem and 
simulation time, memory requirements, and further simulation complications are significantly 
reduced as a result. A few studies have compared the different modelling strategies to propose 
the optimal modelling technique. Gervaso et al., (2008) compared simulation of stent 
deployment in an idealised vessel by direct application of pressure to the inner stent surface 
and also by using a folded balloon model and concluded that modelling the balloon is essential 
to accurately estimate the level of injury to the arterial wall. In another study by De Beule et 
al., (2008), the same two scenarios were compared in a free expansion simulation (without 
inclusion of any vessel) and the pressurisation technique was found to be an over 
simplification which could not yield accurate results. Consistently, in this study comparison of 
case study (i) and case study (iii) illustrates that application of the clinically relevant pressures 
to the stent inner surface neither results in accurate estimation of the stress-strain field in the 
arterial wall nor is it able to predict the transient response, final deformed configuration and 
stresses of the stent.    
The results of case study (ii), however, elucidate that this scenario may have the potential to 
reasonably predict the stress-strain field in the vessel wall. Although this result is shown for a 
particular case of the Multilink stent and a specific vessel geometry, the stresses in the vessel 
wall during deployment of any particular stent are mainly dictated by the expansion diameter 
of the stent and therefore provided that the desired expansion diameter is achieved, utilising 
the method presented in case study (ii) may suffice to model stent deployment.   
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This study illustrates that estimation of the transient response of the stent such as pressure-
diameter, dog-boning and foreshortening is clearly not possible by direct application of 
pressure to the stent inner surface and requires utilisation of a balloon model.  Nevertheless in 
certain cases where the objective is the estimation of the final vessel wall stress/strain field 
following full stent expansion and recoil, use of the method outlined in case study (ii) may be 
adopted as an optimal method in terms of reduced computational costs. In this study a 6% 
error in the estimation of the stent length on full expansion and recoil in case study (ii) did not 
cause any significant alteration in the vessel wall stress magnitudes or spatial distribution. 
However, caution should be exercised when using this method as excessive elongation of the 
stent during direct application of pressure could alter the spatial distribution of the stresses in 
the vessel wall. 
 
Although this study presents a simulation of a balloon expandable stent in a patient derived 
vessel geometry using a realistic three-fold balloon and a three layered vessel, some 
limitations still exist in this study. The most important limitations of this study are associated 
with the vessel wall material properties. Damage to the vessel wall and residual stresses in the 
artery were not included in the material properties of the vessel wall. However, given that this 
is a comparative study which investigates the different modelling strategies, inclusion of 
damage and residual stresses in the vessel wall material model was deemed beyond the scope 
of this work. In addition, human coronary arteries generally exhibit an anisotropic response in 
the axial and circumferential directions due to collagen fibre orientation. The response of the 
vessel wall during stent expansion, however, is mainly dictated by its circumferential 
mechanical properties and therefore in this study the material properties of human coronary 
arterial layers in the circumferential direction were assigned to the models using an isotropic 
material model. 
Although no experimental studies were carried out in this work to verify the numerical results 
obtained, the experimental work carried out by Kiousis et al., (2009) on very similar stent 
designs shows pressure-diameter, dog-boning and foreshortening responses consistent with 
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the results of case study (iii) and provide clear evidence to support the accuracy of this 
approach, see Figure 3-8.   
 
 
Figure ‎3-8 : Experimental results from Kiousis et al. 2009 on the  pressure-diameter, 
dogboning and foreshortening responses of a balloon expandable Express Vascular LD TM 
balloon-stent system under free expansion with a design very similar to the stent modelled 
in this study. 
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4 Chapter 4                                                                                             
Determination of the influence of stent strut thickness using the 
finite element method: implications for vascular injury and in-
stent restenosis 
Many clinical studies, including the ISAR-STEREO trial, have identified stent strut thickness as 
an independent predictor of in-stent restenosis where thinner struts result in lower restenosis 
than thicker struts. The aim of this study was to more conclusively identify the mechanical 
stimulus for in-stent restenosis using results from such clinical trials as the ISAR-STEREO trial. 
The mechanical environment in arteries stented with thin and thicker strut stents was 
investigated using numerical modelling techniques. FE models of the stents used in the ISAR-
STEREO clinical trial were developed and the stents were deployed in idealised stenosed vessel 
geometries in order to compare the mechanical environment of the vessel for each stent. The 
stresses induced within the stented vessels by these stents were compared to determine the 
level of vascular injury caused to the artery by the stents with different strut thickness.  
4.1 Materials and methods 
In the study presented here, FE models of two stents with identical design but different 
thickness were developed and the stents were deployed in an idealised stenosed vessel in 
order to compare the mechanical environment of the vessel for each stent. The stents were 
expanded and deployed within the arteries to scaffold open the stenosed arteries, in line with 
that which was carried out in the ISAR-STEREO trial. Two case studies were investigated to 
determine the influence of stent strut thickness on the vessel wall;  
(i) Both stents were expanded to the same initial maximum stent diameter 
(ii) Both stents were expanded to achieve the same final maximum stent diameter 
taking stent recoil into consideration.  
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Case study 1 represents the clinical situation since stents are routinely expanded under 
fluoroscopy to achieve a ratio of 1.1:1 between the stent diameter and the proximal and distal 
diameter of the host vessel (de Quadros et al., 2006).  
FE analyses were carried out to compare the stresses induced within the stented vessels by 
these stents, and hence to evaluate the potential of arterial injury caused by stents with 
different strut thickness. To generate these numerical simulations, the FEM requires a number 
of inputs; the geometry of the stents and the stenosed coronary arteries, the material 
properties of the stents  and the artery, and the appropriate application of loading and 
boundary conditions, as described below.  
4.1.1 Model Geometry 
The FE models of the stents were generated and meshed in ANSYS (Canonsburg, PA, USA) and 
were generated based on the stents used in the ISAR-STEREO Trial, namely the ACS RX 
MultiLink and the ACS MultiLink RX Duet (Kastrati et al., 2001).  Both stents are manufactured 
by the same company, namely Guidant/Advanced Cardiovascular Systems. Both stents have a 
similar interconnected-ring design, struts with rectangular cross-sectional areas and a width of 
100 μm but different strut thickness.  The strut thickness of the ACS RX MultiLink (Mlinkthin) is 
50 μm and the strut thickness of the ACS MultiLink RX Duet (Mlinkthick) is 140 μm.  Full three-
dimensional models of the stents were developed to determine the expansion characteristics 
of the stents after stent deployment. The main dimensions of the stents were extrapolated 
from a handbook of coronary stents (Serruys et al., 2000).  Both stents are available in a range 
of lengths, whilst the length of the stents investigated in this study was 7.2 mm.  For this 
length, the MultiLink stents consist of six rings in the longitudinal direction with six crowns in 
each ring. 
For both stent models, all of the parameters, such as the length and width were kept constant 
and the only variation between the two designs was the thickness of the struts. Both stents 
were simulated with an inner radius of 0.72mm, with a corresponding outer radius of 0.77mm 
for the Mlinkthin and 0.86mm for the Mlinkthick. 
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The stents are not symmetrical in the longitudinal direction, however, symmetry is observed in 
the circumferential direction.  Due to the circumferential symmetry, only one third was 
modelled in the circumferential direction with the full length in the longitudinal direction.  The 
stent geometry was initially modelled in three-dimensional Cartesian coordinate system, 
representing the stent in an opened-out, planar configuration.  The volumes of Mlinkthin and 
Mlinkthick were discretised by means of eight-noded isoparametric, three-dimensional brick 
elements.  The models of Mlinkthin and Mlinkthick were meshed with two and three elements 
through the thickness respectively, see Figure 4-1.  All elements were checked to ensure that 
no distorted elements were generated. The stent mesh comprised a total number of 7794 
elements for Mlinkthick and 4592 elements for Mlinkthin. The nodal coordinates of the meshed 
model were transferred from a Cartesian coordinate system into a cylindrical coordinate 
system, using a procedure previously reported (Lally et al., 2005) whereby the planar 
configuration was wrapped to represent the cylindrical structure of the stents. 
The FE software used to solve the models was ABAQUS (SIMULIA, Providence, RI, USA). 
ABAQUS explicit was utilized for its robust general contact algorithm and stability which 
enables modelling of very soft hyperelastic materials. The General contact algorithm in 
ABAQUS explicit with no friction between the contacting bodies was considered for the 
analysis which enforces contact constraints using a penalty contact method. The default 
parameters were used to define the contact between the artery and the stent. 
Each simulation model composed two bodies, the stent and the stenotic coronary artery.  The 
thickness of atherosclerotic human coronary arteries range from 0.56 mm to 1.25 mm, 
depending upon the location of the arteries on the surface of the heart (van Andel et al., 
2003).  For this reason, a thickness of 0.8 mm was chosen to represent the stenosed coronary 
artery with the atherosclerotic localised plaque. The stenotic coronary artery was modelled as 
a straight 0.5 mm thick vessel with a localised plaque 0.3 mm thick and an internal radius of 
1.3 mm, see Figure 4-1. Eight node linear brick, reduced integration elements with hourglass 
control (ABAQUS element type C3D8R) were used to mesh the atherosclerotic coronary artery. 
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Six elements were assigned through the thickness of the arterial wall. The vessel was divided 
into three layers; initima, media and adventitia. The thickness of each arterial layer was 
discretized by two elements and each layer was of equal thickness. This closely complied with 
the ratio of the thickness of adventitia, media, and intima which have been reported as 
0.40±0.03, 0.36±0.03, and 0.27±0.02, respectively in (Holzapfel et al., 2005a). Six elements 
were assigned through the plaque thickness in the central region. The atherosclerotic artery 
was meshed by a total of 121,440 elements and 135,969 nodes, see Figure 4-1. 
 
 
 
Figure ‎4-1: FE models of the atherosclerotic coronary arteries with crimped (A) Multilink thin 
and (B) Multilink thick stents. 
  
B 
A 
62 
 
4.1.2 Material Properties 
Layer specific human coronary arterial wall properties were assigned to the artery, consisting 
of the intima, media and adventitia based on the data from Holzapfel et al., (2005a). Human 
cellular atherosclerotic intimal plaque properties were assigned to the localised plaque based 
on the available published data from Loree et al., (1994).  The material of the intima, media 
and adventitia and plaque were defined using third order Ogden hyperelastic constitutive 
equations as described in Chapter 3 and published in (Zahedmanesh and Lally 2009).  
The properties of 316L stainless steel were assigned to the stents’ material. The stress-strain 
relationship of 316L stainless steel for Mlinkthin (strut thickness of 50 µm) and Mlinkthick (strut 
thickness of 140 µm) in the FE models in this study were described by the mechanical 
behaviour of the struts tested by Murphy et al., (2003), see Figure 4-2.  
 
 
Figure ‎4-2 : Stress-strain response of the thick and thin stent struts, adapted from Murphy et 
al. 2003.   
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The material was described as an isotropic material with the linear elastic region of the curve 
defined through the bulk material values for 316L stainless steel; Young’s Modulus of 196GPa, 
Poisson’s Ratio of 0.3. A piecewise linear function was used to represent the non-linear 
plasticity through a von Mises plasticity model with isotropic hardening. 
4.1.3 Boundary Conditions 
The stent deployment involved expansion of the stent by the application of an internal 
pressure on the inner stent surface (loading), and removal of the internal pressure (unloading). 
A uniform, radial pressure was applied as a surface load to the internal surface of the stent 
increasing temporally in magnitude as a smooth step. Connector elements were utilized in 
ABAQUS to stop the stent from further expansion as the desired expansion diameter was 
achieved based on the optimal method described in Chapter 3. These elements were 
connected to the centre of the stent (ground) on one end and to the stent nodes on the other 
end. These connector elements simulate expansion of a stent with a non-compliant 
angioplasty balloon as they prevent the stent from expanding beyond the balloon diameter.  
Two cases were studied to compare the effect of stent strut thickness. In the first case study, 
both Mlinkthin and Mlinkthick, were expanded to the initial maximum external diameter of 3.22 
mm, and were allowed to recoil. In the second case study, the stents were expanded to 
different diameters in such a way as to achieve the same final maximum external diameter 
following radial recoil (3.08 mm). These values were chosen in order to expand the central 
stenosis in the vessel to the diameter of the proximal and distal non-atherosclerotic vessel 
lumen. As the diameter of the stent was found to be non-uniform in different parts of the 
stent following expansion, the maximum external diameter achieved by the stent was opted as 
a criterion for the case studies.     
For both case studies the same FE models were simulated, the only difference being the 
amount of pressure applied.  For case study 1, 0.9 MPa (9 atm) was applied to Mlinkthin and 1.5 
MPa (15 atm) was applied to Mlinkthick, to achieve the same initial maximum external stent 
diameter of 3.22 mm.  For case study 2, the pressure required to expand Mlinkthin and Mlinkthick 
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were 1 MPa (10 atm) and 1.5 MPa (15 atm), respectively, to achieve the same final maximum 
external stent diameter (3.08mm).   
Cyclic symmetry boundary conditions were imposed on the nodes of the stent and artery in 
the circumferential plane of symmetry.  The ends of the stent were free from any constraints. 
Displacement boundary condition was applied to both ends of the vessel to account for in situ 
prestretch of the vessel. Axial in situ prestretch was chosen to be 1.05 which is typical of 
coronary arteries. This is the upper band of the axial in situ stretch of 1.044±0.006 in coronary 
arteries reported by Holzapfel et al., (2005a).  
In addition, element distortion control was used to prevent incorrect results in the contact 
region where excessive distortion of elements could occur.  
When performing a quasi-static analysis with the explicit approach it is necessary to ensure 
that the inertial forces are negligible and do not cause unrealistic dynamic effects. It has been 
shown that by maintaining the ratio of kinetic energy to the total strain energy less than 5% 
dynamic effects are negligible (Kim et al., 2002). This criterion was adopted for the quasi-static 
analyses presented here. 
4.2  Results  
Radial displacements were measured at key locations on each stent through the loading and 
unloading process of the stents’ expansion. The radial recoil throughout both structures of 
Mlinkthin and Mlinkthick was found to be highly non-uniform. The lowest values of recoil were 
observed at the proximal and distal ends of the stent structures because of lower plaque 
thickness at the two ends and the radial recoil was higher for the Mlinkthin when compared 
with Mlinkthick, see Table 4-1. 
Radial recoil was in the order of 3-9%, which is higher than that reported by the manufacturers 
for the laser cut stainless steel multilink stents (1.7-4.8%) (Serruys et al., 1998; Surreys et al., 
2000). This is due to the fact that recoil is generally reported for free expansion of stents whilst 
the presence of the stenotic artery around the stent increased the radial recoil of the stents. 
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Investigating the stresses induced in the arteries by the two stents with different strut 
thickness it was found that the Mlinkthick induced 15% higher stress values in intima than the  
Mlinkthin on loading to achieve the same initial maximum stent diameter, see Figure 4-3.  
However, it was on unloading that the greatest difference in the mechanical environment of 
the vessels was observed. After removal of the expansion pressure the maximum external 
diameter of Mlinkthin and Mlinkthick was found to be 3.02 mm and 3.08, respectively. As a result 
of the higher recoil in the Mlinkthin 64% lower stresses were present in the intima with 17% 
lower stresses induced in the plaque of the vessel scaffolded by this stent, see Figures 4-3 & 4-
4. The percentage stress volume defined as the percentage of the tissue volume stressed over 
a certain threshold to the total volume of the tissue was also calculated. Quantifying the 
volume of plaque and intima tissue stressed at high levels within the vessel it was found that 
the Mlinkthick had higher volumes of tissue stressed at high levels particularly in the intima 
following recoil, see Figure 4-5.  
Table ‎4-1: Radial recoil in the stents 
Stent Pressure 
(atm) 
Stent expanded 
diameter (mm) 
Stent diameter 
following recoil 
(mm) 
Distal 
End 
Centre Proximal 
End 
Mlink thick 15 3.22 3.08 4.54% 5% 4.88% 
Mlinkthin 10 3.40 3.08 6.95% 9.63% 6.52% 
Mlinkthin 9 3.22 3.02 6.56% 6.93% 5.8% 
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Figure ‎4-3: von Mises stresses in the stenosed vessels stented with (A) Multilink thin and (B) 
Multilink thick stents. 
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Figure ‎4-4: von Mises stresses in the intima of the stenosed vessels stented with (A) Multilink 
thin and (B) Multilink thick. 
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Figure ‎4-5: The percentage stress volumes of case study one calculated for intimal tissue 
stressed over 300kPa and plaque tissue stressed over 500kPa 
Stresses in the vessel were also investigated for case study 2, where the stents were expanded 
to achieve the same final maximum stent diameter. Due to the higher radial recoil observed 
for the Mlinkthin it was necessary to expand it to 3.4 mm and the Mlinkthick to 3.22 mm initial 
maximum external diameter to achieve a final maximum external diameter of 3.08 mm in both 
stented vessels. Investigating the stresses in the vessels, it was found that due to the higher 
expansion diameter of the Mlinkthin on loading it induced considerably higher stress 
magnitudes and volumes in the plaque tissue localised where the stent crowns contacted the 
plaque and intima, see Figures 4-3 & 4-4. Removal of the lumen pressure on the stents 
lowered the stresses in the vessels, however, 23% higher stresses were induced in intima by 
Mlinkthick following recoil, see Figures 4-6. 
The results of these models also show that in all cases the plaque and intima of the 
atherosclerotic vessels undergo significantly higher stresses when compared to the media and 
adventitia of the vessels, see Figures 4-3, 4-4, 4-5, 4-6. 
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Figure ‎4-6: The percentage stress volumes of case study two calculated for intimal tissue 
stressed over 300kPa and plaque tissue stressed over 500kPa 
 
4.3 Discussion 
The results of this study show the influence of stent strut thickness on the stresses within a 
vessel. If, as in the ISAR-STEREO clinical trial, two stents with the same design are expanded to 
the same initial maximum stent diameter the recoil of the thinner strut stent will cause lower 
stresses to be induced in the vessel, both acutely during the procedure, and chronically. The 
stresses induced in the vessel on unloading, particularly in the intima, may act as a chronic 
stimulus for cell proliferation where the artery attempts to lower these stresses by vessel 
thickening. The lower lumen gain, but lower acute and chronic stresses, in the thinner strut 
stented vessel may ultimately result in less injury and aggressive healing response.  
This hypothesis and the results from this numerical modelling study are supported further by 
the ISAR-STEREO clinical trial results whereby the diameter stenosis immediately after the 
procedures showed the thin-strut group had less optimal lumen gain but this was found to 
have significantly reversed at 6-month follow-up (see Figure 1 in (Kastrati et al., 2001)). 
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The results from case study 2 show that, although a thinner strut stent may be favourable 
when compared to a thicker strut stent, it only applies in cases where both stents are 
expanded to the same initial maximum stent diameter. Expansion of the thinner strut stent to 
a higher diameter to achieve the same final maximum stent diameter as the thicker strut stent 
results in considerably higher acute stresses at loading, however, at unloading the thicker strut 
stent induces 23% higher intimal stresses. Clearly therefore many stent designs, even thick 
strut stents, could potentially offer a solution to restenosis if the optimum expansion diameter 
was considered such that stresses in the vessel were maintained low.  
Manufacturers quote the recoil of stents but only for free expansion and these compare very 
well to those predicted using numerical models of free expansion. However, experience from 
our lab using commercially available stents has shown that recoil is significantly higher in 
stented vessels when compared to that quoted by manufacturers for free expansion (Toner et 
al., 2007). This is also clearly demonstrated in the models presented here and it demonstrates 
the need for accurate numerical models of medical devices. 
Clearly therefore, a major concern in the response of a vessel to a stent is the stent recoil 
which influences the stresses induced in the vessel, however, overall stent compliance may 
also be a factor influencing restenosis. A more flexible, compliant stent may recoil more than a 
thicker strut, more rigid stent and may also therefore allow greater conformability and 
scaffolding in a tortuous vessel. In addition, arterial vessels contain living cells, such as smooth 
muscle cells (SMCs), which are conditioned to thrive in a cyclic strain environment. Stenting 
lowers vessel compliance and consequently reduces the cyclic strain on these cells (Vernhet et 
al., 2001). Altering the cyclic strain on SMCs may cause cells to proliferate as has been 
indentified in studies on the influence of cyclic loading versus static cells in culture (Morrow 
2005). Specifically, in the study by Colombo (2009) it has been found that reduction of cyclic 
strain due to stenting in mock coronary arteries increases the proliferation of VSMCs which can 
implicate in-stent restenosis. A thinner strut stent may stiffen a vessel to a lesser extent when 
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compared to a thicker strut stent resulting in the cells experiencing closer to the normal cyclic 
strain stimulus.  
The main observations from this study, however, are that a thinner strut stent induces 
considerably lower chronic vessel stresses when expanded to the same initial diameter as a 
thicker strut stent and marginally lower when expanded to the same final diameter as a thicker 
strut stent. Given the lower clinical restenosis rates observed for such thinner strut stents it 
may be postulated that there is a critical chronic stress or injury level above which intimal 
hyperplasia occurs which ultimately results in restenosis. It is this critical stress level that needs 
further investigation in clinical trials. Guidelines on this critical stress level in arteries would 
enable preclinical testing tools to provide better design solutions to the problem of in-stent 
restenosis.  
Some limitations of this study include the use of only circumferential tensile test properties 
and therefore defining the arterial layers as isotropic materials, however, this assumption is 
plausible as the dominant mechanical properties of the arterial wall during stent deployment 
are the circumferential properties. Residual stresses and blood pressure were not included in 
the vessels, however, given the comparative nature of this study the results are not 
compromised. In addition, the tissues were assumed to be purely elastic and damage 
accumulation within the atherosclerotic vessel was not accounted for as it was deemed 
beyond the scope of this study. 
Another factor which has been hypothesised to contribute to the onset of in-stent restenosis is 
alterations in the fluid flow within a vessel, and particularly abnormal wall shear stresses. 
Factors such as the separation and recirculation of the blood downstream from the stent struts 
have been shown to be influenced by strut spacing (Duraiswamy et al., 2007). Although blood 
flow within the stented vessels has not been investigated as part of this study, it is possible 
that alterations in fluid flow would also vary with strut thickness and therefore influence the 
potential for restenotic growth within a stented vessel.  
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In the ISAR-STEREO trial, stent strut thickness was not strictly the only difference between the 
two stent designs implanted. The design of the two models is very similar except for a slightly 
decreased number of inter-ring articulations in the thick-strut stent (ACS Multi-Link RX DUET) 
when compared to the thin strut stent (ACS RX Multi-Link). The clinical study itself, however, 
did not consider these differences significant and therefore simply considered the study an 
investigation of strut thickness. In this study we have adopted a similar approach by solely 
investigating the influence of the strut thickness variation and using the ACS Multi-Link RX 
DUET stent design only.  
Clearly however, the results from the numerical models in this study demonstrate that an 
optimum stent design should recoil sufficiently to prevent overstressing the vessel wall whilst 
maintaining patency of the vessel. This study also provides evidence that preclinical testing 
using numerical modelling can provide insights into the optimum loading for a particular stent 
design to reduce the stimulus for in-stent restenosis. 
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5 Chapter 5                                                                                                          
Bacterial cellulose as a potential vascular graft: Mechanical 
characterisation and constitutive model development 
Bacteria Cellulose (BC) is a novel emerging biomaterial which has shown good 
potential for arterial grafting and vascular tissue engineering. Given that compliance 
mismatch is one of the main factors contributing to the development of intimal 
hyperplasia in vascular replacement conduits, an in depth investigation of mechanical 
properties of BC is required to further support its use in cardiovascular grafting 
applications. The aim of this study was to mechanically characterise bacterial cellulose 
(BC) and also study its potential to accommodate vascular cells. To achieve these aims 
inflation tests and uniaxial tensile tests were carried out on BC samples. In addition, 
dynamic compliance tests were conducted on BC tubes and the results were compared 
to that of arteries, saphenous vein, ePTFE and Dacron grafts. In addition, bovine 
smooth muscle cells and endothelial cells were cultured on BC samples and histology 
and fluorescent imaging analysis were carried out to study cell adherence and 
biocompatibility. Finally, a method to predict the mechanical behaviour of BC grafts in 
situ was established, whereby a constitutive model for BC was determined and used to 
model the BC tubes under inflation using FE analysis.  
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5.1 Materials and methods 
5.1.1 Bacterial Cellulose tubes 
Bacterial cellulose tubes were manufactured by Biosynthetic Blood Vessels (BBV), Gothenburg, 
Sweden and provided for mechanical characterisation experiments. The tubes were produced 
by BBV through fermentation of Acetobacter xylinum subsp.sucrofermentas BPR2001, trade 
number 1700178™, submerged in glass tubes of 70 ml by using a silicone support (Ø4 mm, 
AvantaPure) as an oxygen permeable material. An oxygen ratio of 100% was blown into the 
oxygen permeable material at a rate of 100 ml/min. A complex media was used as described 
previously (Bodin 2007). Four cellulose colonies were grown for two days in a rough flask 
yielding a cell concentration of 3.7 x 106 cfu/ml and later the bacteria were liberated from the 
resulting cellulose by vigorous shaking. 2.5 ml of the bacterial suspension was added to each 
fermentation vessel. The fermentation was completed after 7 days and the BC tubes were 
purified by heating them in 0.1 M NaOH at 60°C for 4 hours and thereafter repeatedly in 
Millipore™ water. The BC tubes were steam sterilized (20 minutes, 120°C) and stored in a 
refrigerator for subsequent mechanical characterisation. 
5.1.2 Inflation tests   
Inflation tests were performed on six bacterial cellulose tubes with 4 mm luminal diameter to 
study the behaviour of the bacterial cellulose tubes under the physiological pressure range. 5 
cm long bacterial cellulose tubes were cut and fixed onto the fittings of a custom built test rig, 
see Figure 5-1. The tubes were inflated using a hydrostatic pressure of a water column 
ramping from 0 to 160 mmHg. Expansion of each tube was determined by measuring the outer 
diameter of the tube using a precise video extensometer (MESSPHYSIK Material Testing, 
Austria) and relating it to the measured initial diameter corresponding to zero pressure. The 
tubes were tested applying no axial prestretch and preconditioning of the tubes was carried 
out before recording expansion by applying ten cycles of pressurization ranging from 0 mmHg 
to 160 mmHg to minimise hysteresis and achieve repeatability.  
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Figure ‎5-1: Custom built inflation and compliance test rig 
5.1.3 Tensile tests 
Uniaxial tensile tests were carried out on samples obtained from the bacterial cellulose tubes 
immediately following the inflation tests to establish the stress-strain response of bacterial 
cellulose and later establish the constitutive material model. The tubes were cut open along 
the axial direction and flat sheets of bacterial cellulose were obtained. Axial and 
circumferential strips were cut out of the tubes. As the structure of BC shows no preferred 
direction in fibre dispersion an isotropic behaviour was expected in the axial-circumferential 
plane. This was confirmed by testing axial samples and comparing with the circumferential test 
results. The tubes did not spring open upon axial cutting indicating that no significant residual 
stress was present in the tubes. The strips were tested using a Zwick displacement controlled 
tensile testing machine utilising a 20 N load cell and the video extensometer was used to verify 
BC Tube 
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that no slippage occurred in the grips and to record the strain in the tests. The thickness of 
each sample was measured using microscopy images of the cross section of the samples which 
showed an average thickness of 0.635±0.2 mm and an average luminal diameter of 4.18±0.12 
mm for the BC tubes. 
Given the tubes were preconditioned during the inflation tests, the uniaxial tensile tests were 
performed immediately following the inflation tests without further preconditioning being 
performed. A preload of 0.001 N was specified for the tensile test machine as the criterion to 
initiate recording strain in all tensile tests.  The samples were stretched to full failure with a 
strain rate of 0.25 mm/s, however the dependence of the stress-strain response on strain rate 
was studied beforehand and proved insignificant. As the samples had the same width within 
and outside the grips they occasionally broke at the grips due to stress concentrations at the 
grip edges. Where this occurred the ultimate tensile strength data was disregarded. This 
limitation was due to the small diameter of the BC tubes rendering preparation of dog bone 
shaped samples difficult. The stress was determined by dividing the instantaneous load by the 
original cross sectional area and the stretch value was derived by dividing the instantaneous 
gauge length by the original gauge length.  
5.1.4 Constitutive modelling 
The concept of pseudo-elasticity was utilized and the loading response was modelled using a 
hyperelastic formulation.  The following Ogden strain energy function, of order three, for an 
isotropic incompressible material was implemented (Ogden 1972):  
Equation ‎5-1 
 
where    denote the isochoric strain energy per unit of reference volume of the 
incompressible hyperelastic material, λ  denotes the deviatoric principal stretches and i  and
i  denote the hyperelastic constants which are established based on the uniaxial tensile test 
data. The nonlinear regression routine available in Abaqus (Simulia, Providence, RI, USA) was 
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used to determine the model that best fit the tensile test data. Although it is possible to fit to 
each individual sample, the average characteristic tensile properties of BC is of interest in this 
study and therefore the average characteristic tensile behaviour was chosen to obtain the 
hyperelastic constants. No restriction was imposed on the material constants and Drucker 
stability criteria (Hibbett and Karlsson 1998) available in Abaqus, was utilised to ensure the 
stability of the model. This confirmed that the second derivative of the strain energy function 
with respect to strain remained positive definite and that the material model was convex.  
5.1.5 Numerical simulations 
A FE simulation of the inflation test was carried out based on the constitutive material model 
established and the results were compared to the results obtained from the experiments. As 
uniaxial tensile tests are theoretically insufficient to fully characterise the three dimensional 
response of an isotropic incompressible material, the numerical simulation of the inflation test 
was used to assess the accuracy of the material model. A 5 cm long cylindrical tube geometry 
was generated. The thickness and diameter of the tube were defined as 0.635 mm and 4.18 
mm respectively, on the basis of the average of those measured from the six bacterial cellulose 
tubes tested.  A uniform luminal pressure ranging from 0 mmHg to 160 mmHg was applied. 
The tube was fully constrained at the two ends thereby representing the tethering applied 
experimentally and the expansion of the tube was determined as the outer diameter divided 
by the initial outer diameter corresponding to zero luminal pressure. The tube was meshed by 
linear hexahedral elements with reduced integration and hybrid formulation and composed of 
a total of 47,670 elements with three elements through the thickness, chosen on the basis of a 
mesh sensitivity study, (see Appendix A-A.2).  
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5.1.6 Compliance measurement 
Diametrical compliance, defined as the inverse of Peterson’s elastic modulus and expressed in 
percent per millimetre of mercury 210 , was determined as follows: 
 
Equation ‎5-2 
where sD  and dD  are the tube diameter in systole and diastole and sP  and dP  are systolic 
and diastolic pressures respectively (Tai et al., 2000). 
Compliance tests were carried out on five BC tubes. The tubes were tethered longitudinally on 
the same rig used for the inflation tests applying no longitudinal prestretch. The rig was then 
connected to a pulsatile flow pump (Harvard Apparatus, USA) and the external diameter of the 
tubes was measured using the video-extensometer. A pediatric pressure catheter (Abbot, IL, 
USA) connected to a pressure sensor (DTXPlus, BD, NJ, USA) and an amplifier and monitoring 
device (TA-100, CWE, PA, USA) were utilised for real time measurement of the intraluminal 
pressure. The mean luminal pressure was increased from 30 to 120 mmHg in increments of 10 
mmHg and the compliance values were determined at each mean luminal pressure by 
application of a pulse pressure of 60 mmHg amplitude consistent with the experiments carried 
out by Sarkar et al., (2006). 
5.1.7 Cell culture experiments 
Bovine aortic SMCs (Coriell AG08504, NJ, USA) were seeded on the luminal and abluminal 
surfaces of the BC tubes using a rotational seeding technique. The tubes were mounted on the 
fittings of a custom built bioreactor similar to the rig shown in Figure 5-1 and autoclaved. Later 
a suspension of SMCs (0.4 million cells/ml) in RPMI 1640 (Sigma R8758) supplemented with 
10% fetal bovine serum (Sigma F9665) and 1% Penicillin-Streptomycin (Sigma P4333) was 
placed into the lumen of the BC tubes and also into the bioreactor space surrounding the BC 
tube to seed the abluminal surface.  The bioreactor was mounted on a rotator and placed in an 
incubator for 24 hours rotating at a speed of 2 rpm to allow homogeneous and confluent cell 
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adherence to the BC surfaces. No adhesion molecule was used for SMC culture. Following 
rotational SMC seeding for 24 hours the bioreactor was connected to a CELLMAX™ flow loop 
and cultured with a media flow of 10.7 ml/min and a pulsatile pressure of 14-21 mmHg for 28 
days in a humidified atmosphere of 95% air, 5% CO2 and a temperature of 37 °C. The culture 
medium was changed every 2 days. In addition, in a separate experiment, bovine ECs (Coriell 
AG08594, NJ, USA) were seeded (125,000 cell/cm2) on the luminal surface of flat BC samples 
pretreated for 1 hour with 20 μg/ml fibronectin (Sigma F1141) and were cultured statically for 
a period of 5 days using the same medium and culture conditions as used for SMCs. 
In order to analyse the cell scaffold interaction the samples were vigorously rinsed with 
phosphate buffered saline to ensure that non-adhering cells were washed off. Samples were 
then fixed in a 10% buffered formalin solution overnight. The nuclei of the cells on the BC 
samples were stained using DAPI and the actin filaments were stained using Phalloidin (Sigma-
Aldrich, St. Louis, MO). In addition separate samples obtained from the BC tubes with SMCs 
were embedded in paraffin and sectioned using standard protocols and were stained using 
hematoxylin (Sigma-Aldrich, St. Louis, MO) and counter stained with Eosin-Y (Sigma-Aldrich, St. 
Louis, MO). The stained samples were observed using a fluorescent microscope (Olympus 
BX51) and images were taken using an integrated camera (Olympus DP30BW). 
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5.2 Results 
5.2.1 Uniaxial tensile tests 
The stress-strain behaviour of all samples tested was found to be highly nonlinear. The cross 
section of bacterial cellulose tubes are composed of two distinct inner and outer layers with a 
denser inner layer and a more porous outer layer (Bäckdahl et al., 2006). The characteristic 
tensile test curves are comprised of four distinct regions; an initial nonlinear region which 
extends to the initiation of failure in the inner layer, a second region which is associated with 
the propagation of failure in the inner layer until rupture of this layer, a third region where 
only the outer layer remains intact and bears the load until a final region where complete 
failure occurs, see Figure 5-2. The ultimate tensile strength was determined based on the 
initial failure of the samples and was found to be 311±29 kPa for all samples that failed within 
the gauge length of 10 mm.   
 
Figure ‎5-2: Characteristic tensile test curve of bacterial cellulose tubes. 
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The stress-strain response of the bacterial cellulose shows variation amongst the samples, see 
Figure 5-3, however a dominant average characteristic behaviour can be seen in samples 3 to 7 
with samples 1 and 10 exhibiting the highest and lowest stiffness behaviour, respectively. Axial 
and circumferential strips did not exhibit different tensile responses which could be due to the 
absence of a preferred fibre orientation of cellulose fibres. The stress-strain response of 
bacterial cellulose in uniaxial tensile tests reveals a nonlinear stress stiffening behaviour 
comprising a toe and a heel region very similar to that of arteries, see Figure 5-3.  
 
 
Figure ‎5-3: Tensile stress-strain response of the preconditioned bacterial cellulose 
specimens, sample 5 (dashed line) is chosen as the average characteristic curve. 
 
 
  
82 
 
This nonlinear stress stiffening response could be attributed to the gradual recruitment of 
cellulose fibres upon loading which is analogous to the function of collagen fibres in arteries 
(Holzapfel 2000b; Holzapfel et al., 2005a). This stress stiffening response is necessary in 
materials chosen for grafts and tissue engineered scaffolds if the compliance of arteries is to 
be matched. In contrast, many synthetic graft materials have linear stress-strain behaviour. 
The stiffness of PTFE, one of the most widely used synthetic graft materials, is significantly 
higher than that of BC, see Figure 5-4. 
 
 
Figure ‎5-4: Curve fits to the tensile test data by the constitutive model proposed (ePTFE data 
adapted from Catanese et al., 1999) 
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5.2.2 Inflation tests and related numerical simulations 
Figure 5-5 shows the pressure-expansion curves of inflation tests obtained for six bacterial 
cellulose tubes. The tests show a nonlinear pressure-expansion response consistent with the 
uniaxial stress-strain response of the material. The stress-strain curve of sample 5, which 
exhibits the average characteristic stiffness, was chosen to determine the hyperelastic 
constants of the constitutive model for BC and the constants that yielded the best fit to the 
experimental data by least-squares error were determined, see Table 5-1. The fit of the 
constitutive model to the stress-strain tensile test results is given in Figure 5-4. The average 
pressure-expansion curve obtained from the inflation tests, along with the pressure-expansion 
curve calculated from the numerical simulation of the inflation test using the hyperelastic 
constitutive model, is also shown in Figure 5-5. Clearly the constitutive model proposed 
captures the nonlinear response of the bacterial cellulose tubes and compares very well with 
the average experimental inflation test results.  
Table ‎5-1: Hyperelastic constants used for modelling characteristic tensile response of BC 
tubes (Zahedmanesh et al., 2011a). 
Hyperelastic constants Value 
   (Pa) -40,841,700.4 
   (Pa) 25,961,863.1 
   (Pa) 14,911,467.2   
   6.860,889,05 
   8.517,152,27 
   3.735,167,42 
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Figure ‎5-5: Inflation test results and comparison with numerical results. Error bars represent 
the standard deviation amongst 6 BC tubes. 
 
5.2.3 Compliance tests 
Compliance test results of the five bacterial cellulose tubes are demonstrated in Figure 5-6. BC 
tubes exhibit varying compliance over the mean luminal pressure range of 30 to 120 mmHg 
and the compliance value lowers with luminal pressure increases. A significant variation in the 
compliance values of the tubes was observed which is consistent with the variations observed 
in tensile and inflation test results. The mean measured compliance of the tubes was found to 
be 4.27±1.51 % per mmHg×10-2 obtained over a mean luminal pressure range of 30 mmHg to 
120 mmHg. 
Dout/Dout (Zero luminal pressure) 
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Figure ‎5-6: Average compliance of the bacterial cellulose tubes in comparison to human iliac 
artery and widely used grafts. Error bars represent the standard deviation for the five BC 
tubes. (Saphenous vein, Artery, Dacron and ePTFE data adapted from Sarkar et al., (2006)) 
5.2.4 Cell culture experiments 
Following 28 days of culture, SMCs infiltrated more than 100 μm into the abluminal side of the 
BC tubes where BC has a more porous structure, see Figure 5-7. In addition the cell culture 
experiments showed a confluent layer of SMCs adhere on the luminal side of the BC tubes, see 
Figure 5-8. However, there was no significant SMC infiltration from the luminal side into the BC 
due to the lower porosity and highly packed fibrous structure on the luminal side of the BC 
tubes. Also, culture of ECs on the luminal side of the BC tubes resulted in good adhesion to the 
luminal surface treated with fibronectin following 5 days of culture, see Figure 5-9. 
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Figure ‎5-7: Histological images of cross sections of bacterial cellulose tubes (abluminal side) 
with SMCs cultured for 28 days stained with H&E. The images show more than 100 μm of 
SMC infiltration into the abluminal side of the BC tubes (Scale bars represents 200 μm). 
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Figure ‎5-8: DAPI and Phalloidin stained fluorescent image of the luminal surface of a BC tube 
seeded with SMCs following 28 days of culture. 
 
Figure ‎5-9: DAPI stained fluorescent image of ECs adhering to the luminal surface of a BC 
sample following 4 days of culture. 
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5.3 Discussion 
To-date the saphenous vein has been the ‘gold’ standard autograft for bypass procedures due 
to poor patency of available synthetic grafts, particularly as small calibre vessel substitutes      
(Catanese et al., 1999). The lack of availability of the saphenous vein in one third of cases due 
to varicosity, previous use or incompatible calibre (Sarkar et al., 2007b) has encouraged 
development of vascular grafts and tissue engineered blood vessels. However most grafts 
suffer from poor patency rates due primarily to thrombogenicity and intimal hyperplasia (IH) 
(Tai et al., 2000). 
Thrombosis formation in vascular grafts depends primarily on the surface properties of the 
grafts and is due to activation of a cascade of events at the blood-graft interface which 
ultimately lead to formation of thrombin, a vital component in blood that facilitates cleavage 
of fibrinogen to fibrin. Fibrin eventually polymerizes to a network that is a main constituent of 
thrombosis. In a recent study by Fink et al., (2010) the material induced blood coagulation of 
ePTFE and Dacron, the two most widely used vascular grafts in clinical application, was 
compared with that of BC and it was concluded that BC induced the least  and slowest 
activation of the coagulation cascade.      
Interestingly, the compliance response of bacterial cellulose tubes reveals a behaviour very 
similar to that of saphenous vein, see Figure 5-6. The compliance of bacterial cellulose tubes 
lowered from a value of 5.96 % per mmHg×10-2 at a mean luminal pressure of 30 mmHg to 
3.15 % per mmHg×10-2 at 120 mmHg which is in fact higher than that of saphenous vein, ePTFE 
and Dacron. This varying compliance response, characteristic of arteries and saphenous vein, is 
not exhibited by grafts such as ePTFE and Dacron and may be the key characteristic 
contributing to graft thrombosis during hypotensive states (Salacinski et al., 2001). 
The interaction of bacterial cellulose with vascular cells, such as that demonstrated here for 
SMCs, may even suggest adaptive remodelling of bacterial cellulose grafts in-vivo and hence 
better compliance matching with host arteries in the long term. This is supported by the work 
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of Greisler et al., (2004) where cellular ingrowth was found to increase the compliance of 
woven polyglactin 910 grafts implanted into rabbits. In addition, in the work by Roy et al., 
(2005) decellularisation of porcine carotid arteries was found to significantly reduce arterial 
compliance. Production of elastin fibres by vascular cells such as SMCs (Seliktar et al., 2003; 
Patel et al., 2006) in the remodelling process of BC grafts could further improve their 
compliance response in the long term following implantation. The similarity of the cellulose 
fibre structure in BC with the collagen network in arteries suggests that elastinogenesis in the 
remodelling process in BC grafts could create a similar structure to arteries. Elastin fibres 
would then bear the load at lower pressures allowing for high extension while the cellulose 
fibres would be progressively recruited with the increase of luminal pressure, functioning like 
collagen fibres in arteries and therefore enhancing the compliance response. This speculation 
however, needs to be investigated by in-vitro and in-vivo implantation experiments. Studies 
have shown that production of extracellular matrix components in tissue engineered scaffolds 
serve to improve the ultimate tensile strength and suture holding properties of the tissue 
engineered blood vessels (Xu et al., 2008) and consequently given its biocompatibility, BC may 
serve as an excellent candidate for tissue engineering if not as a graft. The biodegradability of 
BC in a physiological environment, however, remains to be investigated by in-vivo experiments 
in order to better understand the long term evolution of its mechanical properties following 
implantation. 
The pressure-inflation response of the FE model based on the established constitutive model is 
shown in Figure 5-4. By comparing the numerical simulation results and the experimental 
results of inflation it can be seen that the numerical model does capture the characteristic 
response of the BC tubes during inflation. Although the constitutive model is based on the 
average characteristic tensile behaviour of BC, the numerical model of the inflation captures 
the characteristic response of BC tubes on inflation and the presented approach can be applied 
to the stress-strain curves obtained from each tube to predict the response of the related tube 
upon inflation. Considering the ready availability of accurate constitutive models for most host 
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arteries in the literature numerical models of BC-artery anastomosis can be now used to design 
BC grafts with optimum geometrical and tensile properties to achieve the highest compliance 
matching with different host arteries and also to assess the anastomotic stresses in order to 
minimise the risk of graft failure or injury in the host arteries, see Figure 5-10. One may notice 
the comparably higher stresses within the intimal layer of the host coronary artery due to the 
layer specificity of the model and the higher load bearing capacity of the intima in the aged 
human coronary arteries, see Figure 5-10.  
The inflation and compliance test data shown exhibit considerable variation in the data, 
consistent with the variations observed in the tensile test data, and these variations 
demonstrate that the fabrication parameters for the BC need to be more precisely controlled.  
 
 
 
 
Figure ‎5-10: Circumferential stresses in a BC-Coronary artery anastomosis model under a 
luminal pressure of 120 mmHg, the unloaded diameter and thickness of the BC tube and the 
coronary artery were matched. (Layer specific properties were used for the coronary artery 
using the constitutive model outlined in Chapter 3 and 4) 
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Chapter 6                                                                                                                         
A multi-scale mechanobiological modelling framework using 
agent based models and finite element analysis; Application to 
vascular tissue engineering 
Computational models of mechanobiological systems have been widely used to provide insight 
into these systems and also to predict their behaviour. In this context vascular tissue 
engineering benefits from further attention given the challenges involved in developing 
functional low calibre vascular grafts with long term patency. In this study a novel multi-scale 
mechanobiological modelling framework is presented which takes advantage of lattice free 
agent based models coupled with the FEM to investigate the dynamics of VSMC growth in 
vascular tissue engineering scaffolds. The results illustrate the ability of the mechanobiological 
modelling approach to capture complex multi-scale mechanobiological phenomena. 
Specifically, the framework enabled the study of the influence of scaffold compliance and 
loading regime in regulating the growth of VSMCs in vascular scaffolds and their role in 
development of intimal hyperplasia (IH). The mechanobiological framework presented 
provides a robust platform for testing hypotheses in vascular tissue engineering and lends 
itself to use as an optimisation design tool. 
5.4 Mechanobiological Model 
5.4.1 Mechanobiological model overview 
A mechanobiological modelling framework was developed which comprised of two main 
coupled modules, (i) a module based on the FEM that quantifies cyclic strain (εcyc) and pore 
fluid velocity (Vfluid) as the main regulators of VSMC growth in TEBVs and (ii) a biological 
modelling module based on an agent based model which simulates the key responses of 
VSMCs growth, i.e. migration, proliferation, apoptosis and ECM synthesis in the vascular 
scaffold under the influence of the mechanical stimuli quantified in the FE module, see Figure 
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6-1. In the FE module the value of cyclic strain (εcyc) is calculated as the amplitude of the 
maximum principal strain at each element’s centroid and the pore fluid velocity (Vfluid) was also 
calculated at each element’s centroid as the mean fluid velocity throughout the loading cycle. 
The simulation starts in the FE module and the quantified values of the mechanical stimuli, i.e. 
(εcyc) and (Vfluid), are transferred to the agent based model where the growth of VSMCs is 
simulated under the influence of the mechanical stimuli. Following the agent based simulation 
of cell growth and ECM synthesis, the geometry, boundary conditions and mechanical 
properties of the tissue engineered construct are updated and the updated model is submitted 
to the FE module in order to take the influence of remodelling of mechanical properties due to 
cell growth into account. This iterative approach is repeated until the simulation reaches the 
desired simulation end time, see Figure 6-2. Given that the two modules are loosely coupled, it 
is essential to ensure that each iteration’s time period is small enough to ensure that changes 
of mechanical properties are insignificant during each iteration’s time period. Therefore, in this 
study each iteration’s time period was set to two days which was chosen based on a sensitivity 
analysis, (see Appendix A-A.3). 
A custom written routine was developed using python programming language to enable 
communication between the FE software Abaqus (Simulia, Providence, RI, USA) and the agent 
based modelling framework BREVE (www.Spiderland.org). The same routine also handled the 
tasks necessary for updating the input files of the FE analysis and data mining and processing. 
The agent based model was programmed using the STEVE language specific to the BREVE 
agent based modelling framework. 
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Figure ‎0-1: Detailed system diagram of the components and processes involved in the 
mechanobiological model. Mechanical stimuli quantified in the FE module regulate the 
doubling time, apoptosis rate and ECM synthesis of VSMCs in the ABM model. The 
mechanical properties of each finite element and also the new luminal surface are then 
updated based on the value of ECM synthesised in each element. 
εcyc vfluid 
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Figure ‎0-2: Overall schematic of the mechanobiological modelling framework, the simulation 
starts with a FE analysis where mechanical stimuli are quantified and then the ABM 
determines the VSMC growth under the influence of the mechanical stimuli. Following the 
ABM, the FE model is updated and the iterative approach continues until the simulation end 
time is achieved. 
5.4.2 Finite element module 
An axisymmetric poro-hyperelastic FE model of a tubular scaffold was used to quantify the 
cyclic strain (εcyc) and the pore fluid flow velocity (Vfluid) in the tissue engineered construct. 
Pressure and pore pressure boundary conditions were applied to the luminal surface of the 
tissue engineered construct depending on the lumen pressure while the two ends were 
longitudinally tethered and the pressure and pore pressure boundary conditions were set to 
zero (relative to the ambient pressure) at the abluminal surface. The model is composed of 
(11780) equilateral rectangular axisymmetric elements (Abaqus type CAX4RPH), 8740 of which 
are inactivated luminal elements that are added to the mesh connectivity upon VSMC 
proliferation into the luminal elements and synthesis of ECM. The python code could 
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automatically detect the new luminal surface and apply the pressure and pore pressure 
boundary condition to the new surface following each iteration. The tube was 8 mm long with 
a thickness of 0.673 mm and a luminal diameter of 4.18 mm, which was chosen based on 
dimensions of bacterial cellulose tubes used in Chapter 5 and published in Zahedmanesh et al., 
(2011a) which have shown good potential for vascular tissue engineering. The model was 
discretised by 190 elements longitudinally and 62 elements radially. This mesh density was 
chosen based on mesh sensitivity studies (see Appendix A-A.3). 
Poro-hyperelastic models couple the behaviour of the solid phase and the fluid phase of the 
material both of which are considered as incompressible. The approach employed in (Feenstra 
et al., 2009 and Ayyalasomayajula et al., 2010) was adopted which is based on an effective 
stress concept where an additive decomposition of the stress caused by external loading,   , 
into an effective stress on the matrix of the tissue,  , and an isotropic pore pressure,  , is used 
as follows: 
 
Equation ‎0-1 
 
The pore pressure drives the pore fluid velocity field under the assumption of Darcy’s flow 
(Darcy 1856) as: 
 
Equation ‎0-2 
 
where   is referred to as the effective fluid velocity,  is the porosity of the material,         is 
the pore fluid velocity,   is the permeability of the material and   is the pore pressure 
(Feenstra et al., 2009), see Table 6-1.  
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Table ‎0-1: Porosity and permeability values used in the simulations. Scaffold porosity and 
permeability for the remodelled scaffold were adapted from data in Koshiba et al., (2007) 
and Feenstra et al., (2009) respectively. The bare scaffold data is based on experiments on 
bacterial cellulose arterial scaffolds. 
*(In Abaqus the permeability values should be input with dimensions (L/T) (Abaqus analysis user’s 
manual v6.8), i.e.                       , where    is the density of the wetting liquid,      
         , and   is the magnitude of the gravitational acceleration,        . Hence for the bare 
scaffold,                 and for the remodelled scaffold,                 ). 
Scaffold Initial Porosity of the 
Scaffold,   
*Permeability of the Scaffold,   
          
Bare scaffold 0.86 2.8e-13 
Remodelled Scaffold 0.5 5.7e-16 
 
The porosity in turn is a function of the determinant of the deformation tensor,  , and the 
initial (unloaded) porosity of the material,   , as follows: 
 
Equation ‎0-3 
In order to calculate the effective stress, the following Ogden hyperelastic equation was used 
to model the stress-strain response of the scaffolds and IH tissue (Ogden 1972) considering 
them to be incompressible. 
 
Equation ‎0-4 
Where,   denote the isochoric strain energy density,   i denotes the deviatoric principal 
stretches and μi and αi are the hyperelastic constants, see Table 6-2. 
Table ‎0-2: Coefficients of the Ogden hyperelastic constitutive models (Zahedmanesh and 
lally 2009; Zahedmanesh et al., 2011a) 
Hyperelastic 
constants 
 Low compliance Scaffold Arterial compliant scaffold 
   (Pa) -40,841,700.4 -1,231,144.96 
   (Pa) 25,961,863.1 785,118.59 
   (Pa) 14,911,467.2   453,616.46 
   6.860,889,05 16.59 
   8.517,152,27 16.65 
   3.735,167,42 16.50 
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Two types of scaffold were defined: a low compliance scaffold and a scaffold with a 
compliance similar to that of arteries (arterial compliant scaffold). The stress-strain response of 
a bacterial cellulose scaffold was chosen for the low compliance scaffold (Zahedmanesh et al., 
2011a) and the stress-strain response of human coronary medial layer was opted for the 
compliant scaffold (Zahedmanesh et al., 2009). Where luminal ingrowth occurred, the 
mechanical properties of human coronary media were assigned to the luminal elements given 
that it is mainly composed of VSMCs, see Figure 6-3 and Table 6-2. 
 
Figure ‎0-3: Stress-strain response of the low compliance scaffold (Zahedmanesh et al., 
2011a), arterial compliant scaffolds adapted from (Holzapfel et al., 2005) 
Once cells populate a scaffold they should ideally change its mechanical properties, such as 
compliance and permeability, to that of the native artery. Several scaffolds have shown this 
response such as in the study by Greisler et al., (2004) where cell growth was found to increase 
the compliance of woven polyglactin 910 grafts implanted into rabbits and the study by Song 
et al., (2010) which showed a lowering of initial stiffness of the Poly(Trimethylene Carbonate) 
scaffolds following VSMC culture. In addition, in the work by Roy et al., (2005) decellularisation 
of porcine carotid arteries significantly reduced arterial compliance. Therefore remodelling of 
the mechanical properties of the scaffolds was represented by altering the initial mechanical 
properties of the scaffold i.e. stress-strain response, permeability and porosity to that of 
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arterial tissue (i.e. human coronary media given that media is mainly populated by VSMCs) in 
elements where the ECM content reached a threshold value of ECMThreshold. In addition, the 
luminal elements were also activated when their ECM content reached ECMThreshold. This 
element activation only concerned the FE model and for the agent based model all grid 
elements were available from the beginning. The collagen content in a native artery is 
approximately 3.1×10-4 μg/cell (Hahn et al., 2007). Based on the dimensions of each finite 
element used in this study and dimensions of each VSMC, a maximum of two VSMCs can 
reside in each element. Hence a value of 6.2×10-4 μg/element is the arterial collagen content 
for each element in this study.  
The remodelling threshold value ECMThreshold, was chosen as 3.1×10
-4 μg/Element which 
represents half the arterial collagen content per element given that once the ECM content in 
the construct is higher than this value its mechanical properties are more similar to arteries 
than the original scaffold.  
5.4.3 Agent based module                       
An agent based model of VSMCs seeded confluently on the luminal and abluminal surfaces of a 
vascular scaffold was constructed by assigning one row of cells (250 cells distributed 
homogeneously) to the luminal and abluminal surfaces respectively. Following the FE analysis 
the values of the mechanical stimuli at each element of the FE model are exported to the ABM 
module. In the agent based model, for each mechanical quantity i.e. εcyc and Vfluid, a matrix Ai,j 
is defined where i=the number of FE elements in the longitudinal direction and j=the number 
of FE elements in the radial direction. Each component of the matrix takes the value quantified 
at the centroid of the corresponding FE element. Hence at each point in the ABM domain, the 
value of the corresponding mechanical stimuli can be queried by referring to the related matrix 
component based on the coordinates of the point. This way the FE mesh domain could be 
easily super imposed on the ABM domain. The time step for the ABM simulations was set to 1 
hour given that the experimental data used on cell processes such as cell migration and 
proliferation were obtained on a per hour basis.  
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5.4.3.1  Cell Migration 
The agent based model was a lattice-free model and VSMCs were modelled as spheres with a 
radius equivalent to the average equivalent radius of VSMCs consistent with the approach 
taken in (Caiazzo et al., 2009) in which VSMCs were modelled as spheres in a lattice free agent 
based model of coronary restenosis. VSMCs could migrate in a random walk fashion over the 
ABM domain, see Table 6-3. The same method used for super imposing the values of 
mechanical stimuli on the ABM domain was used to define the values of ECM synthesised by 
VSMCs throughout the ABM domain.  
Table ‎0-3: Parameter values used for migration speed, dimension and ECM synthesis of 
VSMCs 
 
  
Parameter value unit Description and reference 
VSMC migration speed 0.001  mm/hr DiMilla  et al., (1993)  
VSMC radius 12.96 μm Adapted from Peirce et al., (2004) (6×88μm2) 
ECM Threshold 0.00031 μg/element ECM threshold for remodelling into arterial 
tissue. Adapted from Hahn  et al., (2007) 
ECMdep-baseline 1.12e-7 μg/cell.hr Baseline ECM synthesis per hour. Adapted 
from Hahn  et al., (2007) 
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5.4.3.2 Cell Proliferation 
Proliferation was modelled by defining doubling time for each individual cell consistent with 
the approach taken in the ABM model presented in (Peirce et al., 2004).  Each created cell 
records its age and once the age of the cell equals its doubling time the cell undergoes mitosis 
if there is a vacancy surrounding the cell.  The age of the created daughter cells is then 
initiated at 0. Doubling time of VSMCs was defined in hours as a function of cyclic strain      
and pore fluid velocity        as follows:  
Equation ‎0-5 
 
Where         determined the effect of cyclic strain on the doubling time of VSMCs and was 
derived from the experimental work by Colombo (2009) as defined by the following equation, 
see also Figure 6-4.  
Equation ‎0-6 
 
 
Figure ‎0-4: The influence of cyclic strain on the overall doubling time of VSMCs with maximal 
nutrient availability and waste removal. 
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Cartmell et al.,, (2003) studied the influence of pore fluid velocity on cell proliferation using a 
perfusion bioreactor for scaffold inlet flow rates of 0.01, 0.1, 0.2 and 1 ml/min (Cartmell et al., 
2003). The inlet flow rates were converted to pore fluid velocity using an analytical method 
where the mean pore pressure velocity within the scaffold was calculated using the following 
equation consistent with the approach taken in (Stops et al., 2010; Jungreuthmayer et al., 
2009): 
Equation ‎0-7 
Where        is the pore fluid velocity,  is the external inlet flow rate,   is the scaffold 
porosity and r in the chamber radius (Cartmell et al., 2003).  
The contribution of pore fluid velocity to the overall doubling time of VSMCs was then 
described using the data obtained from (Cartmell et al., 2003) which presents the fold change 
in DNA content using the aforementioned flow rates and the static doubling time of VSMCs 
based on Jeong et al., (2005) by the following phenomenological equation, see also Figure 6-5: 
 
Equation ‎0-8 
 
Figure ‎0-5: The influence of pore fluid velocity on the overall doubling time of VSMCs. 
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5.4.3.3 Cell death 
Similar to the proliferation rate, apoptosis rate of VSMCs is dictated by the value of cyclic 
strain that the cells are exposed to (Colombo 2009) and the availability of nutrients and waste 
removal. Therefore the probability of apoptosis for each VSMC was defined as a function of 
the value of the cyclic strain and pore fluid velocity and the apoptotic cells were removed from 
the simulation following every iteration. The apoptosis rate reported in experimental studies 
determines the probability of apoptosis for each cell. A logical statement using a random 
number generator was defined within each cell which had a probability equivalent to the 
apoptosis probability of each cell. Where the statement was true the cell was removed. The 
following function was used to describe the probability of apoptosis for each VSMC: 
Equation ‎0-9 
where         described the influence of cyclic strain on the apoptosis of VSMCs based on the 
data obtained from the experimental study by Colombo (2009) where the influence of cyclic 
strain on VSMC apoptosis was studied in an environment with maximal availability of nutrients 
and waste removal, see also Figure 6-6: 
 Equation ‎0-10 
 
 
Figure ‎0-6: The influence of cyclic strain on the overall apoptosis of SMCs with ample 
availability of nutrients. 
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and           described the influence of pore fluid velocity on Apoptosis of VSMCs based on 
the experimental data on VSMC number in static culture in a fibre matrix (Stankus et al., 2006) 
and assuming an optimal pore fluid velocity above which cell death due to nutrient shortage 
and waste accumulation would not occur (Cartmell et al., 2003) as follows, see also Figure 6-7: 
 
                                                             
 
 
Figure ‎0-7: The influence of pore fluid velocity on the overall apoptosis of VSMCs. 
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5.4.3.4 Protein synthesis 
At each time step of the simulation each cell deposited ECM with an amount of (ECMdeposition) 
representing the amount of collagen synthesis by VSMCs per hour at the corresponding FE 
element. It has been shown that cyclic strain upregulates synthesis of ECM by VSMCs. In the 
study by Kona et al., (2009) collagen production in VSMCs was found to increase two-fold 
when the cells were exposed to 10% cyclic strain. Therefore a linear relation was assumed 
between the ECM synthesis and the value of the cyclic strain as follows in Equation 6-12: 
 
Equation ‎0-12 
Where,                  is the baseline collagen synthesis per hour by VSMCs in static 
condition and      is the value of the cyclic strain, see Table 6-3.  
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5.5 Application of the mechanobiological model                       
The following three main scenarios were simulated using the developed mechanobiological 
modelling framework in order to shed light on the influence of loading regime, remodelling of 
mechanical properties and the scaffold compliance on VSMC growth dynamics, scaffold 
remodelling and development of IH in TEBVs, see Figure 6-8.  
(i) VSMCs were seeded on an arterial compliant scaffold and cultured under 
hypotensive (50-80 mmHg), normotensive (80-120 mmHg) and hypertensive (140-
200 mmHg) luminal pressure and luminal pore pressure to investigate the role of 
loading regime for both in-vivo and in-vitro applications.   
(ii) VSMCs were seeded on an arterial compliant scaffold and cultured under a 
pulsatile luminal pressure and pore pressure of 80-120 mmHg with a frequency of 
1Hz vs. a non-pulsatile pressure of 100 mmHg to study the influence of pulsatile 
flow in in-vitro applications. 
(iii) VSMCs were seeded on low compliance vs. arterial compliant scaffold and cultured 
under a pulsatile luminal pressure and luminal pore pressure of 80-120 mmHg with 
a frequency of 1Hz to study the influence of scaffold compliance for in-vivo and in-
vitro applications. 
 
Figure ‎0-8: Schematic of the modelled tubular scaffold. 
Model domain 
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5.6 Results 
The mechanobiological model enabled the influence of compliance and also the loading 
regime on growth dynamics of VSMCs in vascular scaffolds to be studied. The wall clock time 
for each simulation could reach up to 20 hours depending on the boundary conditions using a 
2GHz processor and single core processing. The results clearly show that mechanical factors 
i.e. loading regime and scaffold compliance play a key role in regulating the growth of VSMCs.  
Comparison of the influence of the three loading regimes of hypotensive, normotensive and 
hypertensive in scenario (i) in all three cases revealed a response composed of a toe and hill 
region where the number of cells increased to a peak value of 12 fold where the curve 
subsequently reached a plateau. At this stage the scaffold was fully packed with cells in all 
three cases, see Figure 6-9. Following 100 days, however, the cell number started to increase 
in all three cases. This increase in the cell number coincided with activation of luminal 
elements given that the amount of extracellular matrix produced in these elements exceeded 
the element activation ECM threshold.  
 
 
Figure ‎0-9: The results of scenario (i). Influence of pulsatile pressure on the number of viable 
cells over time in the arterial compliant scaffold, three loading regimes of hypotensive (50-80 
mmHg), normotensive (80-120 mmHg) and hypertensive (140-200 mmHg) were compared. 
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The main difference in cell number among the three cases, however, started to emerge 
following this point where the cell number was highest in the hypertensive case and lowest in 
the hypotensive regime with values of 20 fold and 15 fold at day 180 respectively.  
Figure 6-10 shows the alterations of pore fluid flow velocity and cyclic strain where the arterial 
compliant scaffold was subject to normotensive pulsatile pressure. It can be seen that pore 
fluid flow velocity, an indicator of nutrient transfer and waste removal, was reduced as the 
cells grew and populated the scaffold. One can notice concentrated zones of high pore fluid 
velocity at day 66 in elements which have a lower ECM content due to the randomness in the 
ABM. Given that the permeability of these elements was higher than the remodelled elements, 
fluid flow founds its way through these elements and hence zones of high fluid velocity were 
temporarily created at these elements. However, these elements were soon remodelled 
leading to a more homogeneous pore fluid velocity field. With the initiation of luminal 
ingrowth, the pore fluid velocity in the scaffold reduced even further given that the activated 
luminal elements further hindered fluid flow through the scaffold. At day 180 the pore fluid 
flow velocity in the core of the scaffold reduced to 0.3 μm/sec which is more than 99% 
reduction compared to day 0. 
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Figure ‎0-10: Influence of pore fluid velocity and cyclic strain on the cell number where the 
arterial compliant scaffold was subject to normotensive pulsatile pressure. (a) cell number 
evolution for 180 days. (b) mean medium flow velocity alterations throughout the 180 days. 
Interestingly, the value of cyclic strain reduced 42% from a maximum initial value of 0.07 at 
day 0 to a value of 0.04 at day 180 which was due to the thickening of the TEBV wall following 
luminal ingrowth. Scenario (ii) on the other hand elucidates the role of pulsatile flow on VSMC 
growth dynamics. In this scenario the loading regime was changed from a pulsatile pressure of 
80-120 mmHg to a constant non-pulsatile pressure of 100 mmHg. In the absence of cyclic 
strain the number of cells increased 31 fold in a period of 160 days with a positive slope 
showing that under this condition cells will continue to proliferate towards the lumen until the 
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vessel is fully occluded, see Figure 6-11.  In stark contrast is the case with pulsatile luminal 
pressure where the number of cells was considerably lower and increased to a maximum of 
14.8 fold in the same period. Figure 6-11 depicts the ABM domain showing the viable cells and 
also the amount of collagen synthesised by VSMCs in the scaffold and in the lumen. One can 
notice that the thickness of the TEBV is doubled where it was cultured under the static luminal 
pressure of 100mmHg compared to the pulsatile luminal pressure of 80-120mmHg. 
Interestingly, the amount of collagen synthesised within the scaffold was higher where the 
TEBV was subject to pulsatile luminal pressure compared to the static case with maximum 
values of 8×10-4 μg/element and 5×10-4 μg/element respectively. This is consistent with the 
findings of most in-vitro studies such as Hahn et al., (2007) and Jeong et al., (2005) which show 
enhanced collagen synthesis in pulsatile flow culture. The values of the collagen content are 
also consistent with the collagen content in arteries as discussed in the previous section.  
 
Figure ‎0-11: Results of scenario (ii). ECM synthesis and viable VSMCs at day 160 (a,c) the 
TEBV was cultured under static pressure of 100 mmHg (b,d) the TEBV was cultured under 
pulsatile pressure of 80-120mmHg. 
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In scenario (iii) the role of scaffold compliance was studied where a low compliance scaffold 
and the arterial compliant scaffold were compared. Consistent with the outcome of clinical 
studies which suggest low compliance of vascular grafts contributes to IH (Salacinski et al., 
2001), our results showed a significantly higher number of cells and luminal ingrowth using the 
low compliance scaffold. In the arterial compliant scaffold a plateau region in the cell number 
curve was achieved for a 75 day interval between the scaffold being fully populated with cells 
and the start of luminal ingrowth, following which the cell number started to increase slightly. 
In stark contrast, in the low compliance scaffold the cell number constantly increased and 
reached a value of 26 fold following 180 days of culture, see Figure 6-12.  
 
 
Figure ‎0-12: Results of scenario (iii) where the influence of scaffold compliance was studied. 
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5.7 Discussion 
We have developed a mechanobiological modelling framework by coupling a lattice free agent 
based model with a FE model that can simulate growth of VSMCs in a TEBV and tissue 
remodelling. The framework allows the role of mechanical factors such as scaffold compliance 
and the loading regime on VSMCs growth to be explored. It also elucidates the significant 
regulatory role that mechanical factors play in vascular tissue engineering which can 
determine the fate of a TEBV and also highlights their role in development of IH.  
One important advantage of the in-silico mechanobiological models is their capability to 
identify the role of each individual parameter involved in the complex multi-scale 
mechanobiological problems such as vascular tissue engineering. Given the numerous 
parameters involved in such systems and their intertwined role, it is often difficult to isolate 
the dominant cause and determine the contribution of each parameter to a specific behaviour 
using in-vivo or even in-vitro experiments. In-silico mechanobiological models enable the 
contribution of each of the involved parameters to the tissue level behaviour to be quantified 
in isolation. The current study illustrates a very good example in this context. The predicted 
nonlinear cell growth response, which is characterised by an increase in cell number to a peak 
value and a subsequent reduction in VSMC growth, is also observed in in-vitro cell culture 
studies on VSMC culture in compliant vascular scaffolds (Jeong et al., 2005), however, the 
timescale of such experimental studies is limited to a few months at best and therefore they 
do not provide much data on luminal ingrowth and IH. It is known that the reduction in the 
permeability of the scaffold, the value of cyclic strain and also cell-cell contact, all play 
significant roles in VSMC growth dynamics, however, when they are all involved in the system, 
the contribution of each factor may not be easily quantified without a computational model. 
Even the influence of cyclic strain cannot be easily determined since although cyclic strain has 
an anti-proliferative and pro-apoptotic effect on VSMCs (Colombo 2009), it can also enhance 
the medium flow in a scaffold and hence improve the proliferation rate. The value of cyclic 
strain can alter along with cell growth due to the remodelling of mechanical properties of the 
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TEBV and also thickening of the TEBV wall. Therefore, determining the role of cyclic strain on a 
TEBV is a challenging task, yet the presented mechanobiological model provides considerable 
insights in this respect. 
Several studies have highlighted the role of compliance on the development of IH and long 
term patency of vascular grafts (Salacinski et al., 2001). Graft compliance can influence 
development of IH in two distinct ways, (i) perturbations of blood flow and shear stress and 
formation of recirculation and flow separation zones which can increase the particle residence 
time and hence increase the luminal concentration of mitogenic factors such as PDGF that 
stimulate luminal ingrowth of VSMCs (Lemson et al., 2000; Salacinski et al., 2001), and (ii) the 
low value of cyclic strain exerted on VSMCs in a graft increases their proliferation rate which 
leads to IH. It’s a very challenging task to determine the contribution of each of these two 
different factors in the development of IH using in-vivo experiments. In-vitro experiments can 
also be challenging in this respect since IH is a long term process and in-vitro experiments can 
be very time consuming, laborious, expensive and prone to the risk of contamination when 
conducted over long timescales.  However, the present mechanobiological model enables the 
influence of cyclic strain on IH to be studied in isolation over a long time scale which is one of 
its important advantages. 
In this context, the results of scenario (i) clearly show that any subtle decrease of cyclic strain 
can initiate a maladaptive path towards occlusion of the TEBV due to IH. Indeed cyclic strain 
played a synergic role given that low cyclic strain contributed to more luminal ingrowth which 
in turn reduced the cyclic strain further and thereby expedited patency loss. Although using an 
arterial compliant scaffold with a normotensive pulsatile luminal pressure leads to a steady 
state cell number for up to 100 days, without an endothelium, VSMCs will still eventually grow 
into the lumen. Therefore, even though the results elucidate the determining role of 
biomechanics in vascular tissue engineering, they also highlight the significance of the 
endothelium and the need for vascular scaffolds with high endothelialisation rates. Such 
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insightful trends would be difficult to ascertain, even qualitatively, using in-vitro experiments, 
while the presented model enables quantitative evaluation of the influence of each parameter. 
Interestingly, the results of scenario (i) show that under a hypertensive luminal pressure the 
VSMC luminal ingrowth is higher compared to normotensive and hypotensive loading regimes. 
Given that the difference in cell number among the three cases emerged following 84 days by 
which the scaffold was fully populated by cells, this observation corroborates clinical studies 
which suggest that hypertension causes thickening and stiffening of arteries (London et al., 
2004). This was mainly due to the stress-stiffening response of the scaffold and IH tissue which 
stiffen at higher pressures and therefore undergo 22% lower cyclic strain in the hypertensive 
pressure compared to the normotenstive pressure.   
The results of scenario (ii) and (iii) both signify the role of cyclic strain in regulating the 
remodelling of tissue engineered blood vessels and development of IH. In scenario (ii) the 
absence of cyclic strain due to bioreactor flow type (i.e. pulsatile vs. non-pulsatile flow) is 
studied while in scenario (iii) low cyclic strain due to mechanical properties of the scaffold is 
studied which can be deciphering both for in-vivo and in-vitro applications.  As shown in Figure 
6-11, the amount of extracellular matrix produced in the vascular scaffold is higher where a 
pulsatile flow culture was used. This is very interesting given that the cell number and luminal 
ingrowth were maintained considerably lower when pulsatile flow culture was used and one 
might presume that due to the higher cell proliferation in the non-pulsatile culture, ECM 
synthesis and therefore remodelling should be enhanced, whilst counter-intuitively the 
pulsatile flow enabled to maintain the cell number and IH at a considerably lower level and in 
the mean while enhance ECM synthesis and remodelling of the scaffold. Obviously this is due 
to the fact that cyclic strain increases ECM synthesis by each VSMC and also the fact that IH 
tissue which is lower in the pulsatile flow culture functions as a barrier to nutrient flow 
through the vessel which reduces cell growth in the scaffold while luminal cells receive ample 
nutrients to continue their ingrowth and increase IH level. In scenario (iii), the IH level is higher 
in the low compliance scaffold as expected intuitively, however one can notice that in the 
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lower compliance scaffold IH continues to increase even after cells populated and remodelled 
the scaffold. This is due to the fact that in the low compliance scaffold a higher level of luminal 
ingrowth occurred from the onset of growth which accounted for IH formation and therefore 
an increase in the thickness of the vessel, see Figure 6-12. Hence, in spite of the fact that the 
mechanical properties were remodelled to the more compliant arterial properties after being 
populated by cells, in the low compliance scaffold the added thickness due to IH reduced the 
cyclic strain value in comparison to the compliant scaffold where cell ingrowth was minimal 
from the onset of growth. 
In order to highlight the influence of pore fluid velocity on VSMC growth, the arterial compliant 
scaffold was cultured under normotensive pulsatile pressure while pore fluid velocity was set 
to zero in Equations 6-8 in an artificial case to isolate the influence of pore fluid velocity in cell 
proliferation. The results showed a considerably lower VSMCs growth rate in the initial phase 
of the curve which prolonged the period of time required to fully populate the scaffold by cells. 
This reduced cell growth rate was maintained throughout the culture period as a lag in growth 
signifying the influence of pore fluid velocity on growth of VSMCs by enhancing nutrient 
transfer and waste removal, see Figure 6-13.   
 
Figure ‎0-13: The influence of pore fluid velocity on VSMC growth dynamics. Pore fluid 
velocity was set to zero in Equation 6-8 to reveal the influence of pore fluid velocity.  
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The results also demonstrate the capability of the presented mechanobiological model to 
pinpoint an optimal tissue engineering approach that would yield the best results following 
implantation of a scaffold or in the in-vitro cell culture experiments. The simulations show that 
the optimal scaffold for vascular tissue engineering should have a compliance similar to 
arteries to minimise IH and enhance ECM synthesis and remodelling. In addition the results 
show that production of ECM at levels consistent with arterial tissue can take up to 6 month 
under optimal biomechanical conditions. Therefore one can conclude that in the context of 
scaffold design, the degradation of a vascular scaffold in the first 6 month period should be 
minimised to reduce the risk of failure. On the other hand in the context of in-vitro cell culture 
experiments the results imply that in order to enhance cell growth and reduce culture time an 
initial non-pulsatile luminal pressure can be used until cells fully populate the scaffold, 
following which a pulsatile luminal pressure can enhance ECM synthesis and scaffold 
remodelling.  
The results clarify an important potential application of the model which is to serve as a 
platform to test existing hypotheses and also generate new hypotheses in vascular tissue 
engineering. The outcome of the simulations can then help to design new in-vitro experiments, 
reduce the experimentation costs, and come up with new tissue engineering strategies 
through identification of the most significant parameters involved which are informed by the 
in-silico model. 
Also from a methodological standpoint, this study presents a novel, yet simple approach to 
achieve more realistic mechanobiological simulations utilizing agent based models by means of 
a straight forward method to couple the available ABM frameworks with FE packages. The 
usefulness of ABMs to investigate higher level patterns originating from local cell-environment 
interactions makes them ideal for tissue engineering applications. ABMs can provide insight 
into mechanisms which drive complex observed phenomena that are not easy to test in the 
laboratory and combining them with FEM can significantly increase their applicability and 
problem solving potential in mechanobiology.  
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In spite of the robustness and novelty of the developed mechanobiological modelling 
framework, the simulations presented in this study have their own limitations. No 
experimental data was used to directly validate the results of this study; however, every 
parameter employed was calibrated with published experiments. Pore fluid flow velocity is 
taken as the indicator of nutrient transport in the TEBV. Although this is a plausible approach 
as discussed earlier in the introduction and is adopted by other studies such as in Stops et al., 
(2010), this study could benefit further from a more sophisticated model of nutrient transport 
and waste removal by solving advection-diffusion equations for the most important 
biochemicals i.e. glucose, oxygen and lactate. However, this would add tremendous complexity 
to the current model and was deemed beyond the scope of this study. While the influence of 
pore fluid flow on VSMCs is interpreted in the context of its effect on nutrient transport and 
waste removal, it can also influence cell behaviour through wall shear stress. Wall shear stress 
due to the luminal flow of medium or due to blood flow may also have an influence on the 
luminal VSMCs behaviour. However, the experiments in our lab show that the influence of 
shear stress on proliferation of VSMCs is trivial in comparison to the effect of cyclic strain. 
Nevertheless, excessively high values of pore fluid velocity and wall shear stress may have an 
adverse effect on VSMCs growth. In addition, given Cartmell et al., (2003) used osteoblast-like 
cells in their experiments which formed the basis of the equations used in this study on the 
influence of pore fluid flow velocity on cell behaviour, Equations 6-8 and 6-11 need to be 
ascertained using experimental data dedicated specifically to VSMCs. After all, they serve to 
illustrate how the model can be applied provided such experimental data on VSMCs were 
available. Development of IH depends on several factors such as endothelialisation of the 
scaffold and the immune system activation, however, endothelialisation has been shown to be 
very poor on most available synthetic grafts (Zilla et al., 2007) and was therefore excluded in 
this study. Nevertheless, this study aimed at elucidating the contribution of mechanical factors 
to remodelling and development of IH rather than prediction of the IH level. Another limitation 
of this study which benefits from further investigation is that the scaffold is assumed to be a 
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homogeneous medium, however most scaffolds have a heterogeneous microstructure which 
can have an important influence on the value of mechanical stimuli at the cell level and also on 
cell dynamics such as migration rate. The mechanical properties of the construct were updated 
depending on the value of ECM using a threshold based function. Although this is a 
simplification, a more realistic model requires experimental data on the evolution of 
mechanical properties i.e. permeability, porosity, and stress-strain relationship which was not 
available. Finally, Equation 6-6 concerning the role of cyclic strain on proliferation of VSMCs 
may not be applied to pathological levels of cyclic strain (>15%) given the different 
mechanisms of mechanotransduction at excessively high levels of cyclic strain. 
Nevertheless, In spite of these simplifications, the model presented in this study is the first of 
its kind dedicated to the study of the mechanobiological environment of VSMCs in vascular 
tissue engineering and it clearly captures the key characteristics of VSMC growth in TEBVs 
comprising of nonlinear growth of TEBVs with time, ECM synthesis, remodelling and IH 
development.   
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6 Chapter 7                                                                                                                 
Final Discussion 
Several mechanical factors are involved in the design of stents and vascular grafts which have a 
determining influence on their implantation outcome. Vascular injury caused by the stent due 
to high stresses in the vessel wall is identified as the main cause of in-stent restenosis 
(Schwartz et al., 1992; Kornowski et al., 1998; Mitra et al., 2006). On the other hand 
mechanical compliance mismatch between vascular grafts and host arteries, usually due to the 
low compliance of vascular grafts, has been found to significantly contribute to intimal 
hyperplasia (Salacinski et al., 2001).  Furthermore, the important role of mechanoregulation in 
vascular tissue engineering has been shown by many studies (Seliktar et al., 2003; Jeong et al., 
2005; Hahn et al., 2007; Xu et al., 2008). In these studies In-vitro mechanical stimulation of 
tissue engineered blood vessels has been shown to significantly enhance extracellular matrix 
synthesis and thereby improve the mechanical properties of vascular scaffolds, the majority of 
which suffer from low compliance and low burst pressure. 
Computational technology enables us to simulate and quantify the complex in-vivo 
biomechanical environment in arteries and their interaction with implanted vascular devices. 
In many occasions computational modelling offers the only solution to the biomechanical 
challenges involved in vascular device technology. Such techniques, in conjunction with 
appropriately designed experiments, are helping us better understand the links between 
biomechanics and arterial pathologies.  
One important advantage of computational models over experimental models is that 
computational models enable each individual biomechanical factor involved in the design of 
vascular devices to be studied in isolation. It is often extremely difficult to study the causative 
role of one single parameter using in-vivo and even in-vitro experiments. For instance, in this 
study, the influence of stent strut thickness on the level of arterial injury was studied from an 
arterial biomechanics viewpoint where the stresses induced in the arterial wall were the 
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matter of concern. The presented computational model complements the clinical studies such 
as ISAR-STEREO, which merely state a perceived causative link between stent-strut thickness 
and in-stent restenosis (Kastrati et al., 2001) by elucidating the mechanisms by which strut 
thickness contributes to the level of in-stent restenosis. Hence, novel design solutions can be 
developed in light of the identified causative mechanisms. The computational model combined 
with the in-vivo studies such as ISAR-STERO then corroborates the general hypothesis that 
vascular injury is the main cause of in-stent restenosis. 
A fundamental question which needs to be answered before developing computational models 
is to rationalise the extent to which the system of interest should be simplified. Indeed, 
modelling is nothing but simplification of complex phenomena to a level that we can deal with 
their complexity and still reasonably capture the key characteristic behaviours of the system. 
Obviously excessive simplification of a system will lead to a model that totally fails to capture 
the key responses of interest. On the other hand, including too many details will lead to a 
model which is as complex as the system itself, if not more complex. Therefore the key 
question that needs to be answered in order to develop a good model of a complex system 
such as the biomechanical systems is “How much simplification is plausible?”. The modeller 
should come up with a rationale by which the key factors which contribute to the behaviours 
of interest can be determined. This constitutes the first and most critical step towards 
development of a deductive biomechanical model and is indeed an important distinctive 
feature of different models developed to study the same phenomena.  
This study addresses some of the most complex challenges involved in the biomechanical 
modelling of vascular implants namely stents, vascular grafts and tissue engineered blood 
vessels. Hence the critical choice of the level of simplification was a main focus throughout all 
computational models presented in this study. Chapter 3 is specifically dedicated to address 
this crucial choice in modelling stent deployment procedures. Stent deployment procedures 
constitute a difficult problem from a biomechanical modelling perspective given the strong 
nonlinearity arising from the stress-strain response of arteries, the elasto-plastic response of 
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stents, the complex balloon geometry and its nonlinear unfolding response and last but not 
least, the contact problem between balloon-stent and stent-artery pairs. In spite of all the 
aforementioned challenges, the benefits that computational models bring have urged 
engineers to use computational models as an important part of the stent design cycle. 
Nonetheless, the majority of studies have resorted to a high level of simplification without 
providing a strong rationale for their choice of simplification. Considering the significant value 
of FEM as a formidable preclinical testing tool which can shorten the design cycle time for 
vascular stents and lower experimentation costs, it was necessary to thoroughly investigate 
the different levels of simplification used in stent deployment modelling and provide a basis 
for this critical choice as far as accuracy and efficiency of models are concerned. For this 
purpose a model with the minimum possible simplification was first developed and then stent 
deployment was modelled using the most widely used simplified models in order to determine 
the sensitivity of the models to the varying levels of simplification. Namely, the balloon 
deployment procedure was modelled including a realistic model of a three-fold balloon and 
later the same simulations were performed using the more simplified methods such as direct 
application of homogeneous pressure to inner stent surface with and without constraining 
elements. The results clearly showcased how critical the choice of simplification level is in a 
model. The study showed that the majority of the simplified methods fail to capture many key 
characteristics of stent expansion i.e. expansion diameter, dogboning and foreshortening, 
specifically in the transient phase. Furthermore, the study proposed a straight forward method 
to develop an exhaustive model of stent deployment procedures whereby all necessary details 
of stent response, its interaction with the vessel wall and the vessel stresses could be captured 
with high accuracy. An alternative and more efficient method was also proposed and its 
limitations were clearly discussed which can be used in certain circumstances, specifically 
when the transient phase of stent deployment is not the main interest of the modeller. The 
methods presented in Chapter 3 can be utilised in the stent design cycle to reduce the arterial 
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wall stresses and hence arterial injury in order to address the issue of in-stent restenosis as 
showcased in Chapter 4. 
In the case of vascular grafts, however, the main biomechanical challenge is the issue of 
compliance mismatch and this study presented a method to ensure compliance matching with 
different host arteries using computational modelling. In chapter 5, a basis for modelling the 
in-situ mechanical response of vascular grafts is provided using custom-tailored experiments in 
conjunction with FE modelling. Arteries within the body have significantly different mechanical 
and geometrical properties depending on their type and function. Therefore in order to ensure 
compliance matching, grafts needs to be designed specifically for each different host artery. 
The presented method in chapter 5, whereby a constitutive model is presented for bacterial 
cellulose vascular grafts, enables the optimum graft material and geometrical design 
parameters to be determined in order to ensure compliance matching. Compliance matching 
not only reduces the level of intimal hyperplasia but also reduces the anastomotic stresses and 
thereby lowers the risk of graft rupture and injury to the host arteries. In addition, constitutive 
models for vascular grafts are necessary to study hemodynamics related factors which have 
also been postulated to contribute to development of intimal hyperplasia (Salacinski et al., 
2001). Hemodynamic related factors such as wall shear stress depend on the elastic properties 
of arteries which necessitates coupled field fluid-solid interaction models that require accurate 
constitutive models for wall mechanics. Even though, currently mechanical constitutive models 
are mainly developed based on experiments conducted on cadaveric tissues and the results 
are generalised, with recent developments in non-invasive methods such as intravascular 
ultrasound elastography (de Korte et al., 2002), it would be possible to develop patient specific 
constitutive models for different arteries which would enable even better compliance 
matching of vascular grafts with host arteries using the FEM. 
One important aspect of constitutive model development for mechanical response of 
materials is the appropriate choice of mechanical characterisation tests. Soft tissues are 
usually characterised using tensile tests. Several types of tensile tests may be conducted based 
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on the number of axes that extensions are applied to the material, including uniaxial, biaxial 
and multiaxial extension tests. Theoretically speaking, In order to fully characterise the three 
dimensional mechanical response of an incompressible isotropic material it is necessary to 
conduct biaxial experiments (Holzapfel et al., 2009). However, uniaxial extension tests are very 
popular and many studies use them to develop constitutive models which are also used to 
model the response of vascular conduits under multi-axial loading conditions. This is mainly 
due to the fact that preparation of intact patches for biaxial tests is difficult to achieve and 
often not feasible at all. In addition, equi-biaxial experiments are often conducted rather than 
general biaxial tests given that availability of devices that allow independent control of 
extensions and stress in more than one direction is limited. Furthermore uniaxial extension 
tests allow for a higher level of extension compared to biaxial tests and therefore can better 
capture the nonlinear stress stiffening response of soft tissue. Nevertheless, it is necessary to 
verify that the constitutive models developed based on uniaxial extension tests can also 
accurately capture the response of material under more general loading cases such as inflation 
(Holzapfel et al., 2009). In chapter 5, an approach was illustrated whereby a model of bacterial 
cellulose tubes under inflation was developed using a constitutive model based on uniaxial 
extension tests. The model results were then compared to actual inflation tests to verify the 
accuracy of the constitutive model in capturing the response of bacterial cellulose tubes under 
luminal pressures similar to those that the tubes undergo in-vivo. In this specific case where 
bacterial cellulose was under investigation, the constitutive model developed based on 
uniaxial tests was capable of accurately capturing the response of the bacterial cellulose tubes 
under inflation. There are also many studies which exemplify feasibility of using uniaxial tests 
to develop constitutive models for arteries such as the studies by Holzapfel et al., (2000a, 
2005a), however, this should not be over-generalised given that there are also materials such 
as human annulus fibrosus where uniaxial tests have been shown to be insufficient to 
characterise their in-vivo response (Bass et al., 2004). 
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Complex biomechanics of the arteries and vascular devices only constitutes the first challenge 
in arterial biomechanics. The main complexity however, arises from the ability of arterial 
systems to remodel in response to the alterations in their mechanical environment by adapting 
their structure and morphology. Cells are central to this adaptation and therefore 
mechanobiological models are needed to determine how cells respond to the biomechanical 
signals received from their environment. The fact that mechanical loads are applied at tissue 
level and adaptation stems from cell level behaviours necessitate a multi-scale modelling 
approach whereby the mechanical signals that cells receive from their environment (cell level 
loads) are quantified based on the tissue level mechanical loads such as the pulsatile blood 
pressure in arteries. Then the quantified signals can be used to determine cellular behaviours. 
In addition to how cells respond to an altered mechanical environment, the most intriguing 
and yet complicated problem is that tissue level responses such as intimal hyperplasia in 
vascular grafts and tissue engineered blood vessel emerge not only from the behaviour of 
individual cells, but also from the intracellular interaction within cell societies. Hence, novel 
methods in computational biology such as agent based modelling have been developed which 
enable the response of multi-cellular biological systems or cell societies to be modelled based 
on interactions amongst cells. Agent based modelling is a robust and versatile platform 
whereby the collective response of cell societies can be modelled through defining simple rules 
of behaviour for each cell type and allowing the cells to interact based on the rules of 
behaviour, thereby the complex emergent collective behaviours of cell societies can be 
modelled. The rules of behaviour are defined at the cell level and include the important cell 
functions such as migration, mitosis, differentiation, protein synthesis and also how each 
individual cell responds to signals it receives from the neighbouring cells. Agent based 
modelling has been utilised in many studies which lend themselves to studying complex 
biological phenomena such as wound healing, tissue patterning, pathogensis of 
atherosclerosis, and tissue vascularisation (Walker et al., 2004; Baily et al., 2007; Pappalardo et 
al., 2009). The novel idea which formed the basis of Chapter 6, was to combine agent based 
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modelling with the FEM to develop a robust mechanobiological modelling framework which 
allows some of the most important challenges in vascular tissue engineering to be addressed, 
namely mechanoregulation of remodelling and development of intimal hyperplasia.  
Tissue engineering seems to be a promising approach in the treatment of vascular disease, 
however there are still several challenges that need to be addressed before it can be widely 
practiced clinically. An important challenge for tissue engineers is how mechanical factors can 
influence the remodelling of vascular scaffolds. However, in spite of the fact that 
computational models can provide significant insights in this context, a relatively small number 
of computational studies have focussed on vascular tissue engineering. A tremendous volume 
of data has been generated by in-vitro experiments in this field pertaining to the discovery of 
various chemo-mechano-biological pathways, however, they have not shed light on how these 
numerous factors and pathways combine to contribute to certain key characteristics of 
interest such as scaffold remodelling. This leads to the issue discussed earlier in this chapter 
regarding the rationale for simplification of complex systems in order to come up with models 
that can reasonably capture the key responses of interest in vascular tissue engineering. In 
addition to highly concentrated in-vitro and in-vivo studies focused on discovering new 
pathways, it is necessary to develop a platform that allows all the different pathways that are 
hypothesised to be involved in a complex matter such as remodelling, to be studied in a 
systematic and collective manner in order to come up with rationale which determine the key 
causative factors and mechanisms.  Such a platform will then help to corroborate or rule out 
our hypotheses about the role of mechanical factors in remodelling and ultimately lend itself 
to developing novel methods in vascular tissue engineering informed by mechanics related 
cues. 
The need for such a platform in vascular tissue engineering motivated the development of a 
robust and novel mechanobiological modelling framework by coupling agent based models 
with FE analysis as discussed in Chapter 6. The framework was used to study the influence of 
mechanical loading regime for in-vivo conditioning of vascular scaffolds to enhance their 
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remodelling. In addition the role of scaffold compliance on growth dynamics of vascular 
smooth muscle cells and development of intimal hyperplasia was investigated. In light of these 
findings, it may be concluded that it is possible to regulate the key characteristic behaviours of 
smooth muscle cell in tissue engineered blood vessels utilising a combination of strategies 
based on mechanical factors, i.e. scaffold compliance and external loads. 
Interestingly, the mechanobiological modelling framework highlighted the significant role of 
cyclic strain in regulating the growth of VSMCs and development of IH which showed that 
VSMCs within TEBVs should undergo a physiological level of cyclic strain to minimise IH. In 
addition to the fact that this finding of the mechanobiological model is consistent with the 
clinical findings which suggest a direct relationship between the compliance of vascular grafts 
and their long term patency rates, it also relates to the findings of the clinical studies on stents 
such as ISAR-STEREO trial which show that the restenosis rate is lower when thin strut stents 
which are more compliant are used. Clearly therefore, the developed mechanobiological 
modelling framework could be employed to study restenosis following stent implantation.   
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7 Chapter 8                                                                                                   
Conclusions & Future work 
7.1 Conclusions 
The overall aim of this study was to develop computational models which can help improve 
the performance of vascular stents and vascular grafts as the key vascular implants used in 
surgical treatment of vascular disease.  
With regard to the stents the specific aim was to develop FE models that can accurately predict 
the mechanical behaviour of stents during stent deployment procedures and following stent 
placement which enable optimisation of stent design parameters in order to reduce arterial 
wall stresses and hence arterial injury which is the main cause of in stent restenosis. The 
findings of this study can be summarised as follows: 
 The transient response of balloon expandable stents can only be captured using a 
balloon model and the simplified models where a uniform pressure is applied to the 
inner stent surface are incapable of capturing the transient response. 
 Application of direct pressure to the inner stent surface was found to be incapable of 
accurately predicting the stress-strain field and the deformed configuration of the 
stent both in the transient phase and also following stent expansion and recoil. The 
use of restraining elements, however, which prevent expansion of the stent beyond 
the desired diameter combined with the application of a uniform pressure to the inner 
stent surface, with a magnitude high enough to achieve the desired expansion 
diameter, may be used as a computationally efficient method to predict the stress-
strain field in the vessel wall following full stent expansion and recoil. 
 Studying the influence of stent strut thickness on the arterial wall stresses revealed 
that thinner strut stents induce lower chronic stresses in the vessel wall which could 
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explain the lower restenosis rates using thin strut stents in comparison to thicker strut 
stents as reported by clinical trials such as ISAR-STEREO.  
 This study supports the hypothesis that arteries develop restenosis in response to 
injury, where high vessel stresses are a good measure of that injury. The study points 
to a critical stress level in arteries, above which an aggressive healing response leads to 
in-stent restenosis in stented vessels. Stents can be designed to reduce stresses in this 
range in arteries using preclinical tools such as numerical modelling. 
Vascular grafts were categorised into (i) synthetic vascular grafts and (ii) tissue engineered 
blood vessels and treated separately in this study.  
The specific aim of this study with respect to synthetic vascular grafts was to use FE modelling 
to ensure compliance matching between vascular grafts and host arteries in order to minimise 
intimal hyperplasia. The findings of this study are as follows: 
 Bacterial cellulose was identified as a suitable vascular scaffold based on compliance 
tests and preliminary cell seeding experiments. 
 A preclinical test method has been developed which successfully provides a means to 
optimise graft material and scaffold or graft geometrical design parameters to ensure 
compliance matching and to prevent graft failure and injury in the host arteries. 
With respect to tissue engineered blood vessels the specific aim was to develop a 
computational mechanobiological model to simulate mechanoregulation of remodelling in 
vascular tissue engineered scaffolds in order to develop novel strategies in vascular tissue 
engineering informed by biomechanics related cues. The main findings of this study in this 
context are as follows: 
 Agent based models coupled with FE analysis can be used as a robust 
mechanobiological modelling framework for multi-scale mechanobiological modelling 
in vascular tissue engineering. By comparison to published in-vitro and in-vivo studies, 
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the mechanobiological modelling framework was found to capture the key 
characteristics of VSMC growth in TEBVs. 
 The model generated valuable insights into the mechanobiological processes which 
drive the remodelling process and regulate VSMC growth dynamics in tissue 
engineered blood vessels and elucidated the role of mechanical factors such as 
scaffold compliance and loading regime. 
7.2 Future work 
Following on from the significant insights gained from the models presented in this thesis, the 
computational tools developed could be further improved and applied as follows: 
  The influence of anisotropic arterial mechanical properties on the arterial wall 
stresses following stent deployment could be assessed. 
 The influence of stent induced damage to the arterial wall on arterial wall stresses and 
stent recoil could be investigated by using an appropriate damage model for the 
arterial constitutive model 
 The influence of inhomogeneous mechanical properties of atherosclerotic plaques 
could be studied using imaging modalities such as MRI and intra vascular ultrasound 
and also ultrasound elastography to better evaluate the stresses in the atherosclerotic 
arteries and also the risk of plaque rupture. 
 In-vitro and In-vivo studies could be run to corroborate the mechanobiological 
modelling framework developed.  
 By incorporating advection-diffusion equations in the mechanobiological modelling 
framework the transport of oxygen, glucose and lactate in tissue engineered 
constructs could be better modelled. 
 The mechanobiological modelling framework could be applied to other areas such as 
skeletal tissue engineering and fracture healing. 
129 
 
  The mechanobiological modelling framework can be employed to study in-stent 
restenosis. 
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9 Appendix A  
 
A.1: Mesh sensitivity for the simulations presented in Chapter 3 
 
Figure A-‎9-1:  Mesh sensitivity analysis for the stent deployment simulations using 
restraining elements. 
 
A.2: Mesh sensitivity for the simulations presented in Chapter 5 
 
Figure A-‎9-2: Mesh sensitivity analysis for FE model of BC tubes inflation using the 
constitutive model developed for BC tubes, 3 elements through the thickness of the BC tubes 
proved adequate to model their inflation response.  
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A.3 Sensitivity analyses for simulations presented in Chapter 6 
 
 
Figure A-‎9-3: The sensitivity of the simulation results to each iteration’s time period. A test 
simulation was run using three different time periods of 7 days, 2 days and 1 day for each 
iteration’s time period based on which a period of two days was chosen for the simulations. 
 
 
Figure A-‎9-4: Mesh convergence analysis where compliant scaffold was studied. 16 elements 
through the thickness of the scaffold proved sufficient. 
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